NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

National Collaborating Centre for Women's and Children's Health (UK). Antenatal Care: Routine Care for the Healthy Pregnant Woman. London: RCOG Press; 2008 Mar. (NICE Clinical Guidelines, No. 62.)

Cover of Antenatal Care

Antenatal Care: Routine Care for the Healthy Pregnant Woman.

Show details

References (2003 version)

1.
Expert Maternity Group. Woman centred care. Changing Childbirth. Report of the Expert Maternity Group. Department of Health; London: HMSO; 1993. pp. 5–8.
2.
Garcia J, Loftus-Hills A.National Perinatal Epidemiology Unit: Oxford University. An overview of research on women’s views of antenatal care. Personal communication. 2001.
3.
Singh D, Newburn M, editors. Access to Maternity Information and Support; the Experiences and Needs of Women Before and After Giving Support. London: National Childbirth Trust; 2000.
4.
Cochrane AL. Effectiveness and efficiency, Random reflections on health services. London: Nuffield Provincial Hospitals Trust; 1972. [PubMed: 2691208]
5.
Department of Health. Screening for infectious diseases in pregnancy: standards to support the UK antenatal screening programme. 2003. [In preparation]
6.
National Institute for Clinical Excellence. Information for national collaborating centres and guideline development groups, Guideline development process series 3. London: Oaktree Press; 2001.
7.
Henderson J, McCandlish R, Kumiega L, Petrou S. Systematic review of economic aspects of alternative modes of delivery. BJOG. 2001;108:149–57. [PubMed: 11236114]
8.
Bekker H, Thornton JG, Airey CM, Connelly JB, Hewison J, Robinson MB, et al. Informed decision making: An annotated bibliography and systematic review. Health Technology Assessment. 1999;3(1):1–156. [PubMed: 10350446]
9.
Department of Health. Changing childbirth, Report of the Expert Maternity Group. London: HMSO; 1993.
10.
Audit Commission for Local Authorities, NHS in England and Wales. First class delivery: improving maternity services in England and Wales. London: Audit Commission Publications; 1997. pp. 1–98.
11.
Murray J, Cuckle H, Sehmi I, Wilson C, Ellis A. Quality of written information used in Down syndrome screening. Prenatal Diagnosis. 2001;21:138–42. [PubMed: 11241543]
12.
Thornton JG, Hewison J, Lilford RJ, Vail A. A randomised trial of three methods of giving information about prenatal testing. British Medical Journal. 1995;311:1127–30. [PMC free article: PMC2551055] [PubMed: 7580707]
13.
O’Cathain A, Walters SJ, Nicholl JP, Thomas KJ, Kirkham M. Use of evidence based leaflets to promote informed choice in maternity care: randomised controlled trial in everyday practice. [comment] British Medical Journal. 2002;324:643. [PMC free article: PMC84396] [PubMed: 11895822]
14.
Stapleton H. Qualitative study of evidence based leaflets in maternity care. British Medical Journal. 2002;324:639. [PMC free article: PMC84395] [PubMed: 11895821]
15.
Dodds R, Newburn M. Support during screening: an NCT report. Modern Midwife. 1997;7:23–6. [PubMed: 9233225]
16.
Carroll JC, Brown JB, Reid AJ, Pugh P. Women’s experience of maternal serum screening. Canadian Family Physician. 2000;46:614–20. [PMC free article: PMC2144979] [PubMed: 10752000]
17.
Marteau TM, Slack J, Kidd J, Shaw RW. Presenting a routine screening test in antenatal care: practice observed. Public Health. 1992;106(2):131–41. [PubMed: 1376931]
18.
Smith D, Shaw RW, Marteau T. Lack of knowledge in health professionals: a barrier to providing information to patients. Quality in Health Care. 1994;3:75–8. [PMC free article: PMC1055200] [PubMed: 10137588]
19.
Smith DK, Shaw RW, Slack J, Marteau TM. Training obstetricians and midwives to present screening tests: evaluation of two brief interventions. Prenatal Diagnosis. 1995;15:317–24. [PubMed: 7617573]
20.
Green JM. Serum screening for Down’s syndrome: experiences of obstetricians in England and Wales. British Medical Journal. 1994;309:769–72. [PMC free article: PMC2541020] [PubMed: 7950560]
21.
Michie S, Marteau TM. Non-response bias in prospective studies of patients and health care professionals. International Journal of Social Research Methodology. 1999;2:203–12.
22.
Marteau TM. Towards informed decisions about prenatal testing: a review. Prenatal Diagnosis. 1995;15(13):1215–26. [PubMed: 8710763]
23.
National Health Service. The Pregnancy Book. London: Health Promotion England; 2001.
24.
Bro Taf Health Authority. Tests for you and your baby during pregnancy. Cardiff, Wales: Bro Taf Health Authority; 2000.
25.
Nolan ML, Hicks C. Aims, processes and problems of antenatal education as identified by three groups of childbirth teachers. Midwifery. 1997;13:179–88. [PubMed: 9511685]
26.
Johnson R, Slade P. Does fear of childbirth during pregnancy predict emergency caesarean section? BJOG. 2002;109:1213–21. [PubMed: 12452457]
27.
Gagnon AJ. Individual or group antenatal education for childbirth/parenthood. Cochrane Database of Systematic Reviews. 2001;(3) [PubMed: 11034780]
28.
Hibbard BM, Robinson JO, Pearson JF, Rosen M, Taylor A. The effectiveness of antenatal education. Health Education Journal. 1979;38:39–46.
29.
Rautauva P, Erkkola R, Sillanpaa M. The outcome and experiences of first pregnancy in relation to the mother’s childbirth knowledge: The Finnish Family Competence Study. Journal of Advanced Nursing. 1991;16:1226–32. [PubMed: 1757689]
30.
Lumley J, Brown S. Attenders and nonattenders at childbirth education classes in Australia: how do they and their births differ? Birth. 1993;20:123–30. [PubMed: 8240618]
31.
Sullivan P. Felt learning needs of pregnant women. Canadian Nurse. 1993;89:42. [PubMed: 8425171]
32.
Villar J, Khan-Neelofur D. Patterns of routine antenatal care for low–risk pregnancy. Cochrane Database of Systematic Reviews. 2003;(1) [PubMed: 10796217]
33.
Hodnett ED. Continuity of caregivers for care during pregnancy and childbirth. Cochrane Database of Systematic Reviews. 2001;(3) [PubMed: 18843605]
34.
Waldenstrom U, Turnbull D. A systematic review comparing continuity of midwifery care with standard maternity services. British Journal of Obstetrics and Gynaecology. 1998;105:1160–70. [PubMed: 9853764]
35.
North Staffordshire Changing Childbirth Research Team. A randomised study of midwifery caseload care and traditional ‘shared care’ Midwifery. 2000;16:295–302. [PubMed: 11080465]
36.
Homer CS, Davis GK, Brodie PM, Sheehan A, Barclay LM, Wills J, et al. Collaboration in maternity care: a randomised controlled trial comparing community-based continuity of care with standard hospital care. BJOG. 2001;108:16–22. [PubMed: 11212998]
37.
Homer CS, Davis GK, Brodie PM. What do women feel about community-based antenatal care? Australian and New Zealand Journal of Public Health. 2000;24:590–5. [PubMed: 11215006]
38.
Biro MA, Waldenstrom U. Team midwifery care in a tertiary level obstetric service: a randomized controlled trial. Birth. 2000;27:168–73. [PubMed: 11251497]
39.
Waldenstrom U. Does team midwife care increase satisfaction with antenatal, intrapartum, and postpartum care? A randomized controlled trial. [see comments.] Birth. 2000;27:156–67. [PubMed: 11251496]
40.
Blondel B, Breart G. Home visits for pregnancy complications and management of antenatal care: an overview of three randomized controlled trials. British Journal of Obstetrics and Gynaecology. 1992;99:283–6. [PubMed: 1533787]
41.
Lilford RJ, Kelly M, Baines A, Cameron S, Cave M, Guthrie K, et al. Effect of using protocols on medical care: randomised trial of three methods of taking an antenatal history. British Medical Journal. 1992;305:1181–4. [PMC free article: PMC1883806] [PubMed: 1467719]
42.
Elbourne D, Richardson M, Chalmers I, Waterhouse I, Holt E. The Newbury Maternity Care Study: a randomized controlled trial to assess a policy of women holding their own obstetric records. British Journal of Obstetrics and Gynaecology. 1987;94:612–19. [PubMed: 3304403]
43.
Homer CS, Davis GK, Everitt LS. The introduction of a woman-held record into a hospital antenatal clinic: the bring your own records study. Australian and New Zealand Journal of Public Health. 1999;39:54–7. [PubMed: 10099751]
44.
Lovell A, Zander LI, James CE, Foot S, Swan AV, Reynolds A. The St. Thomas’s Hospital maternity case notes study: a randomised controlled trial to assess the effects of giving expectant mothers their own maternity case notes. Paediatric and Perinatal Epidemiology. 1987;1:57–66. [PubMed: 3506191]
45.
Petrou S, Kupek E, Vause S, Maresh M. Antenatal visits and adverse perinatal outcomes: results from a British population-based study. European Journal of Obstetrics Gynecology and Reproductive Biology. 2003;106:40–9. [PubMed: 12475580]
46.
Carroli G, Villar J, Piaggio G, Khan-Neelofur D, Gulmezoglu M, Mugford M, et al. WHO systematic review of randomised controlled trials of routine antenatal care. Lancet. 2001;357:1565–70. [PubMed: 11377643]
47.
Clement S, Sikorski J, Wilson J, Das S, Smeeton N. Women’s satisfaction with traditional and reduced antenatal visit schedules. Midwifery. 1996;12:120–8. [PubMed: 8938091]
48.
Hildingsson I, Waldenstrom U, Radestad I. Women’s expectations on antenatal care as assessed in early pregnancy: Number of visits, continuity of caregiver and general content. Acta Obstetricia et Gynecologica Scandinavica. 2002;81:118–25. [PubMed: 11942901]
49.
Henderson J, Roberts T, Sikorski J, Wilson J, Clement S. An economic evaluation comparing two schedules of antenatal visits. Journal of Health Services and Research Policy. 2000;5:69–75. [PubMed: 10947550]
50.
Kaminski M, Blondel B, Breart G. Management of pregnancy and childbirth in England and Wales and in France. Paediatric and Perinatal Epidemiology. 1988;2:13–24. [PubMed: 3070482]
51.
Ryan M, Ratcliffe J, Tucker J. Using willingness to pay to value alternative models of antenatal care. Social Science and Medicine. 1997;44(3):371–80. [PubMed: 9004371]
52.
Crowther CA, Kornman L, O’Callaghan S, George K, Furness M, Willson K. Is an ultrasound assessment of gestational age at the first antenatal visit of value? A randomised clinical trial. [see comments] British Journal of Obstetrics and Gynaecology. 1999;106:1273–9. [PubMed: 10609721]
53.
Savitz DA, Terry JW Jr, Dole N, Thorp JM Jr, Siega-Riz AM, Herring AH. Comparison of pregnancy dating by last menstrual period, ultrasound scanning, and their combination. American Journal of Obstetrics and Gynecology. 2002;187:1660–6. [PubMed: 12501080]
54.
Backe B, Nakling J. Term prediction in routine ultrasound practice. Acta Obstetricia et Gynecologica Scandinavica. 1994;73:113–8. [PubMed: 8116348]
55.
Tunon K, Eik-Nes SH, Grottum P. A comparison between ultrasound and a reliable last menstrual period as predictors of the day of delivery in 15000 examinations. Ultrasound in Obstetrics and Gynecology. 1996;8:178–85. [PubMed: 8915087]
56.
Blondel B, Morin I, Platt RW, Kramer MS, Usher R, Breart G. Algorithms for combining menstrual and ultrasound estimates of gestational age: consequences for rates of preterm and post-term birth. BJOG. 2002;109:718–20. [PubMed: 12118654]
57.
Neilson JP. Ultrasound for fetal assessment in early pregnancy. Cochrane Database of Systematic Reviews. 1999;(2) [PubMed: 20393930]
58.
Moutquin J-M, Gagnon R, Rainville C, Giroux L, Amyot G, Bilodeau R, et al. Maternal and neonatal outcome in pregnancies with no risk factors. Canadian Medical Association Journal. 1987;137:728–32. [PMC free article: PMC1267309] [PubMed: 3651944]
59.
Mohamed H, Martin C, Haloob R. Can the New Zealand antenatal scoring system be applied in the United Kingdom? Journal of Obstetrics and Gynaecology. 2002;22:389–91. [PubMed: 12521461]
60.
Doyle P, Roman E, Beral V, Brookes M. Spontaneous abortion in dry cleaning workers potentially exposed to perchloroethylene. Occupational and Environmental Medicine. 1997;54:848–53. [PMC free article: PMC1128964] [PubMed: 9470891]
61.
Kolstad HA, Brandt LP, Rasmussen K. [Chlorinated solvents and fetal damage. Spontaneous abortions, low birth weight and malformations among women employed in the dry-cleaning industry]. [Danish] Ugeskrift for Laeger. 1990;152:2481–2. [PubMed: 2402826]
62.
Kyyronen P, Taskinen H, Lindbohm ML, Hemminki K, Heinonen OP. Spontaneous abortions and congenital malformations among women exposed to tetrachloroethylene in dry cleaning. Journal of Epidemiology and Community Health. 1989;43:346–51. [PMC free article: PMC1052872] [PubMed: 2614324]
63.
Mozurkewich EL, Luke B, Avni M, Wolf FM. Working conditions and adverse pregnancy outcome: A meta-analysis. Obstetrics and Gynecology. 2000;95:623–35. [PubMed: 10725502]
64.
Hanke W, Kalinka J, Makowiec-Dabrowska T, Sobala W. Heavy physical work during pregnancy: a risk factor for small-forgestational-age babies in Poland. American Journal of Industrial Medicine. 1999;36:200–5. [PubMed: 10361607]
65.
Kramer MS. Nutritional advice in pregnancy. Cochrane Database of Systematic Reviews. 2003;(1):1–10.
66.
Abramsky L, Botting B, Chapple J, Stone D. Has advice on periconceptional folate supplementation reduced neural-tube defects? Lancet. 1999;354:998–9. [PubMed: 10501365]
67.
Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database of Systematic Reviews. 2002;(1) [PubMed: 21491380]
68.
Li Z, Gindler J, Wang H, Berry RJ, Li S, Correa A, et al. Folic acid supplements during early pregnancy and likelihood of multiple births: a population-based cohort study. Lancet. 2003;361:380–4. [PubMed: 12573374]
69.
Royal College of Obstetricians and Gynaecologists. Periconceptual folic acid and food fortification in the prevention of neural tube defects, Scientific Advisory Committee Opinion Paper No. 4. London: RCOG; 2003.
70.
Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects. Implications for prevention. JAMA. 1995;274:1698–702. [PubMed: 7474275]
71.
Expert Advisory Group. Department of Health, Scottish office Home and Health Department, Welsh Office, and Department of Health and Social Services, Northern Ireland. Folic acid and the prevention of neural tube defects. London: HMSO; 1992.
72.
Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group [see comments] Lancet. 1991;338:131–7. [PubMed: 1677062]
73.
Wald NJ, Law MR, Morris JK, Wald DS. Quantifying the effect of folic acid. Lancet. 2001;358:2069–73. [PubMed: 11755633]
74.
Mahomed K. Iron and folate supplementation in pregnancy. Cochrane Database of Systematic Reviews. 2001;(2) [PubMed: 17636654]
75.
Hemminki E, Rimpela U. A randomized comparison of routine versus selective iron supplementation during pregnancy. Journal of the American College of Nutrition. 1991;10:3–10. [PubMed: 2010577]
76.
Mahomed K. Iron supplementation in pregnancy. Cochrane Database of Systematic Reviews. 2001;(2) [PubMed: 10796140]
77.
British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary. London: Mar, 2003. pp. 439–40.
78.
van den Broek N, Kulier R, Gulmezoglu AM, Villar J. Vitamin A supplementation during pregnancy. Cochrane Database of Systematic Reviews. 2003;(1):1–21. [PubMed: 21069669]
79.
Dolk HM, Nau H, Hummler H, Barlow SM. Dietary vitamin A and teratogenic risk: European Teratology Society discussion paper. European Journal Obstetrics and Gynecology Reproductive Biology. 1999;83:31–6. [PubMed: 10221607]
80.
Oakley GP Jr, Erickson JD. Vitamin A and birth defects. Continuing caution is needed. New England Journal of Medicine. 1995;333:1414–15. [PubMed: 7477124]
81.
Rothman KJ, Moore LL, Singer MR, Nguyen US, Mannino S, Milunsky A. Teratogenicity of high vitamin A intake. New England Journal of Medicine. 1995;333:1369–73. [PubMed: 7477116]
82.
Mahomed K, Gulmezoglu AM. Vitamin D supplementation in pregnancy. Cochrane Database of Systematic Reviews. 2000;(1) [PubMed: 10796185]
83.
Southwick FS, Purich DL. Intracellular pathogenesis of listeriosis. New England Journal of Medicine. 1996;334:770–6. [PubMed: 8592552]
84.
Public Health Laboratory Service Press Release. Disease Facts: Salmonella. 2001.
85.
British Nutrition Foundation. BNF Information. Diet through Life: Pregnancy. 2003. [Accessed 20 August 2003]. [ www​.nutrition.org.uk/]
86.
Ledward RS. Drugs in pregnancy, Progress in Obstetrics and Gynaecology. Studd J, editor. Edinburgh: Churchill Livingstone; 1998. pp. 19–46.
87.
Fugh-Berman A, Kronenberg F. Complementary and alternative medicine (CAM) in reproductive-age women: a review of randomized controlled trials. Reproductive Toxicology. 2003;17:137–52. [PubMed: 12642146]
88.
Moore ML. Complementary and alternative therapies. Journal of Perinatal Education. 2002;11:39–42. [PMC free article: PMC1595096] [PubMed: 17273285]
89.
Pinn G, Pallett L. Herbal medicine in pregnancy. Complementary Therapies in Nursing and Midwifery. 2002;8:77–80. [PubMed: 12188161]
90.
Leung K-Y, Lee Y-P, Chan H-Y, Lee C-P, Tang MHY. Are herbal medicinal products less teratogenic than Western pharmaceutical products? Acta Pharmacologica Sinica. 2002;23:1169–72. [PubMed: 12466056]
91.
Hepner DL, Harnett M, Segal S, Camann W, Bader AM, Tsen LC. Herbal medicine use in parturients. Anesthesia and Analgesia. 2002;94:690–3. [PubMed: 11867399]
92.
Maats FH, Crowther CA. Patterns of vitamin, mineral and herbal supplement use prior to and during pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2002;42:494–6. [PubMed: 12495093]
93.
Tsui B, Dennehy CE, Tsourounis C. A survey of dietary supplement use during pregnancy at an academic medical center. American Journal of Obstetrics and Gynecology. 2001;185:433–7. [PubMed: 11518905]
94.
Medicines Control Agency. Safety of Herbal Medicinal Products. London: 2002. pp. 22–23.
95.
Ernst E. Herbal medicinal products during pregnancy: are they safe? BJOG. 2002;109:227–35. [PubMed: 11950176]
96.
Dove D, Johnson P. Oral evening primrose oil: Its effect on length of pregnancy and selected intrapartum outcomes in low-risk nulliparous women. Journal of Nurse-Midwifery. 1999;44:320–4. [PubMed: 10380450]
97.
Simpson M. Raspberry leaf in pregnancy; its safety and efficacy in labor. Journal of Midwifery and Women’s Health. 2001;46:51–9. [PubMed: 11370690]
98.
Gallo M, Sarkar M, Au W, Pietrzak K, Comas B, Smith M, et al. Pregnancy outcome following gestational exposure to Echinacea: a prospective controlled study. Archives of Internal Medicine. 2000;160:3141–3. [PubMed: 11074744]
99.
Goldman RD, Koren G. Motherisk Team. Taking St John’s wort during pregnancy. Canadian Family Physician. 2003;49:29–30. [PMC free article: PMC2214117] [PubMed: 12602839]
100.
Clapp JF III, Simonian S, Lopez B, Appleby-Wineberg S, Harcar-Sevcik R. The one-year morphometric and neurodevelopmental outcome of the offspring of women who continued to exercise regularly throughout pregnancy. American Journal of Obstetrics and Gynecology. 1998;178:594–9. [PubMed: 9539531]
101.
Kramer MS. Aerobic exercise for women during pregnancy. Cochrane Database of Systematic Reviews. 2002;(4) [PubMed: 12076383]
102.
Camporesi EM. Diving and pregnancy. Seminars in Perinatology. 1996;20:292–302. [PubMed: 8888455]
103.
Read JS, Klebanoff MA. Sexual intercourse during pregnancy and preterm delivery: effects of vaginal microorganisms. American Journal of Obstetrics and Gynecology. 1993;168:514–19. [PubMed: 8438920]
104.
Klebanoff MA, Nugent RP, Rhoads GG. Coitus during pregnancy: is it safe? Lancet. 1984;2:914–7. [PubMed: 6148629]
105.
Berghella V, Klebanhoff M, McPherson C. Sexual intercourse association with asymptomatic bacterial vaginosis and Trichomonas vaginalis treatment in relationship to preterm birth. American Journal of Obstetrics and Gynecology. 2002;187:1277–82. [PubMed: 12439520]
106.
Walpole I, Zubrick S, Pontre J. Is there a fetal effect with low to moderate alcohol use before or during pregnancy? Journal of Epidemiology and Community Health. 1990;44:297–301. [PMC free article: PMC1060673] [PubMed: 2277251]
107.
Borges G, Lopez-Cervantes M, Medina-Mora ME, Tapia-Conyer R, Garrido F. Alcohol consumption, low birth weight, and preterm delivery in the national addiction survey (Mexico) International Journal of the Addictions. 1993;28(4):355–68. [PubMed: 8463022]
108.
Holzman C, Paneth N, Little R, Pinto-Martin J. Perinatal brain injury in premature infants born to mothers using alcohol in pregnancy. Pediatrics. 1995;95:66–73. [PubMed: 7770312]
109.
Aronson M, Hagberg B, Gillberg C. Attention deficits and autistic spectrum problems in children exposed to alcohol during gestation: A follow-up study. Developmental Medicine and Child Neurology. 1997;39:583–7. [PubMed: 9344050]
110.
Abel EL. Fetal alcohol syndrome: the ‘American Paradox’ Alcohol and Alcoholism. 1998;33:195–201. [PubMed: 9632044]
111.
Royal College of Obstetricians and Gynaecologists. Alcohol consumption in pregnancy, Guideline No. 9. London: RCOG; 1999.
112.
Lumley J, Oliver S, Waters E. Interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews. 2001;(2):2001. [PubMed: 10796228]
113.
Owen L, McNeill A, Callum C. Trends in smoking during pregnancy in England, 1992–7: quota sampling surveys. British Medical Journal. 1998;317:728. [PMC free article: PMC28663] [PubMed: 9732341]
114.
DiFranza JR, Lew RA. Effect of maternal cigarette smoking on pregnancy complications and sudden infant death syndrome. Journal of Family Practice. 1995;40:385–394. [PubMed: 7699353]
115.
Ananth CV, Smulian JC, Vintzileos AM. Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy: A meta-analysis of observational studies. Obstetrics and Gynecology. 1999;93:622–8. [PubMed: 10214847]
116.
Castles A, Adams EK, Melvin CL, Kelsch C, Boulton ML. Effects of smoking during pregnancy: Five meta-analyses. American Journal of Preventive Medicine. 1999;16:208–15. [PubMed: 10198660]
117.
Shah NR, Bracken MB. A systematic review and meta-analysis of prospective studies on the association between maternal cigarette smoking and preterm delivery. American Journal of Obstetrics and Gynecology. 2000;182:465–72. [PMC free article: PMC2706697] [PubMed: 10694353]
118.
Wyszynski DF, Duffy DL, Beaty TH. Maternal cigarette smoking and oral clefts: a meta-analysis. Cleft Palate-Craniofacial Journal. 1997;34:206–10. [PubMed: 9167070]
119.
Conde-Agudelo A, Althabe F, Belizan JM, Kafury-Goeta AC. Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. American Journal of Obstetrics and Gynecology. 1999;181:1026–35. [PubMed: 10521771]
120.
Clausson B, Cnattingius S, Axelsson O. Preterm and term births of small for gestational age infants: A population-based study of risk factors among nulliparous women. British Journal of Obstetrics and Gynaecology. 1998;105:1011–7. [PubMed: 9763054]
121.
Raymond EG, Cnattingius S, Kiely JL. Effects of maternal age, parity and smoking on the risk of stillbirth. British Journal of Obstetrics and Gynaecology. 1994;101:301–6. [PubMed: 8199075]
122.
Kleinman JC, Pierre MB Jr, Madans JH, Land GH, Schramm WF. The effects of maternal smoking on fetal and infant mortality. American Journal of Epidemiology. 1988;127:274–82. [PubMed: 3337083]
123.
Lumley J. Stopping smoking. British Journal of Obstetrics and Gynaecology. 1987;94:289–92. [PubMed: 3580311]
124.
MacArthur C, Knox EG, Lancashire RJ. Effects at age nine of maternal smoking in pregnancy: experimental and observational findings. BJOG. 2001;108:67–73. [PubMed: 11213007]
125.
von Kries R, Toschke AM, Koletzko B, Slikker W Jr. Maternal smoking during pregnancy and childhood obesity. American Journal of Epidemiology. 2002;156:954–61. [PubMed: 12419768]
126.
Faden VB, Graubard BI. Maternal substance use during pregnancy and developmental outcome at age three. Journal of Substance Abuse. 2000;12:329–40. [PubMed: 11452837]
127.
Thorogood M, Hillsdon M, Summerbell C. Changing behaviour: cardiovascular disorders. Clinical Evidence. 2002;8:37–59. [PubMed: 12603872]
128.
Law M, Tang JL. An analysis of the effectiveness of interventions intended to help people stop smoking. Archives of Internal Medicine. 1995;155:1933–41. [PubMed: 7575046]
129.
Wisborg K, Henriksen TB, Jespersen LB, Secher NJ. Nicotine patches for pregnant smokers. Obstetrics and Gynecology. 2000;96:967–71. [PubMed: 11084187]
130.
Hajek P, West R, Lee A, Foulds J, Owen L, Eiser JR, et al. Randomized controlled trial of a midwife-delivered brief smoking cessation intervention in pregnancy. Addiction. 2001;96:485–94. [PubMed: 11255587]
131.
Stotts A, DiClemente CC, Dolan-Mullen P. One-to-one. A motivational intervention for resistant pregnant smokers. Addictive Behaviors. 2002;27:275–92. [PubMed: 11817768]
132.
Moore L, Campbell R, Whelan A, Mills N, Lupton P, Misselbrook E, et al. Self help smoking cessation in pregnancy: cluster randomised controlled trial. British Medical Journal. 2002;325:1383–6. [PMC free article: PMC138509] [PubMed: 12480850]
133.
Li C, Windsor R, Perkins L, Lowe J, Goldenberg R. The impact on birthweight and gestational age of cotinine validated smoking reduction during pregnancy. JAMA. 1993;269:1519–24. [PubMed: 8445814]
134.
Windsor R, Li C, Boyd N, Hartmann K. The use of significant reduction rates to evaluate health education methods for pregnant smokers: a new harm reduction – behavioral indicator. Health Education and Behavior. 1999;26:648–62. [PubMed: 10533170]
135.
Fergusson DM, Horwood LJ, Northstone K. ALSPAC Study Team, Avon Longitudinal Study of Pregnancy and Childhood. Maternal use of cannabis and pregnancy outcome. BJOG. 2002;109:21–7. [PubMed: 11843371]
136.
English DR, Hulse GK, Milne E, Holman CD, Bower CI. Maternal cannabis use and birth weight: a meta-analysis. Addiction. 1997;92:1553–60. [PubMed: 9519497]
137.
Royal College of Obstetricians and Gynaecologists. Advice on preventing deep vein thrombosis for pregnant women travelling by air, Scientific Advisory Committee Opinion paper No. 1. London: RCOG; 2001.
138.
James KV, Lohr JM, Deshmukh RM, Cranley JJ. Venous thrombotic complications of pregnancy. Cardiovascular Surgery. 1996;4:777–82. [PubMed: 9013009]
139.
McColl MD, Ramsay JE, Tait RC, Walker ID, McCall F, Conkie JA, et al. Risk factors for pregnancy associated venous thromboembolism. Thrombosis and Haemostasis. 1997;78:1183–8. [PubMed: 9364982]
140.
Kierkegaard A. Incidence and diagnosis of deep vein thrombosis associated with pregnancy. Acta Obstetricia et Gynecologica Scandinavica. 1983;62:239–43. [PubMed: 6624397]
141.
Scurr JH, Machin SJ, Bailey-King S, Mackie IJ, McDonald S, Coleridge Smith PD. Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial. Lancet. 2001;357:1485–9. [PubMed: 11377600]
142.
Martinez L, editor. World Health Organization. Travellers with special needs, International Travel and Health. Geneva: World Health Organization; 2002.
143.
Lewis G, Drife J, editors. Why mothers die 1997–1999: The fifth report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. London: RCOG Press; 2001.
144.
Johnson HC, Pring DW. Car seatbelts in pregnancy: the practice and knowledge of pregnant women remain causes for concern. BJOG. 2000;107:644–7. [PubMed: 10826580]
145.
Chang A, Magwene K, Frand E. Increased safety belt use following education in childbirth classes. Birth. 1987;14:148–52. [PubMed: 3689510]
146.
Klinich KD, Schneider LW, Moore JL, Pearlman MD. Investigations of crashes involving pregnant occupants Annual Proceedings, Association for the Advancement of Automotive Medicine20004437–55. [PMC free article: PMC3217378] [PubMed: 11558095]
147.
Crosby WM, Costiloe JP. Safety of lap-belt restraint for pregnant victims of automobile collisions. New England Journal of Medicine. 1971;284:632–6. [PubMed: 5545604]
148.
Crosby WM, King AI, Stout LC. Fetal survival following impact: improvement with shoulder harness restraint. American Journal of Obstetrics and Gynecology. 1972;112:1101–6. [PubMed: 5017639]
149.
Wolf ME, Alexander BH, Rivara FP, Hickok DE, Maier RV, Starzyk PM. A retrospective cohort study of seatbelt use and pregnancy outcome after a motor vehicle crash. Journal of Trauma-Injury Infection and Critical Care. 1993;34:116–19. [PubMed: 8437176]
150.
Martinez L, editor. World Health Organization. Special groups, International Travel and Health. Geneva: World Health Organization; 2002.
151.
Hurley PA. International travel and the pregnant women, Progress in Obstetrics and Gynaecology. Studd J, editor. Edinburgh: Churchill Livingstone; 2003. pp. 45–55.
152.
Hurley P. Vaccination in pregnancy. Current Obstetrics and Gynaecology. 1998;8:169–75.
153.
Jothivijayarani A. Travel considerations during pregnancy. Primary Care Update for Ob/Gyns. 2002;9:36–40.
154.
World Health Organization. Martinez L, editor. International Travel and Health. Geneva: World Health Organization; 2002. [Accessed 4 September 2003]. Treatment of P. vivax, P. ovale and P. malariae infections. [ www​.who.int/ith/chapter07_04.html]
155.
Luxemburger C, McGready R, Kham A, Morison L, Cho T, Chongsuphajaisiddhi T, et al. Effects of malaria during pregnancy on infant mortality in an area of low malaria transition. American Journal of Epidemiology. 2001;154:459–65. [PubMed: 11532788]
156.
World Health Organization. World malaria situation in 1993, Part 1. Weekly Epidemiological Record. 1996;71:17–24. [PubMed: 8924385]
157.
Linday S, Ansell J, Selman C, Cox V, Hamilton K, Walraven G. Effect of pregnancy on exposure to malaria mosquitoes. Lancet. 2000;355:1972. [PubMed: 10859048]
158.
Schaefer C, Peters PW. Intrauterine diethyltoluamide exposure and fetal outcome. Reproductive Toxicology. 1992;6:175–6. [PubMed: 1591475]
159.
Dolan G, ter Kuile FO, Jacoutot V. Bed nets for the prevention of malaria and anaemia in pregnancy. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1993;87:620–6. [PubMed: 8296357]
160.
Pearce G. Travel insurance and the pregnant woman. MIDIRS Midwifery Digest. 1997;7:164.
161.
Brown H, Campbell H. Special considerations for pregnant travellers. Modern Medicine of Australia. 1999;42:17–20.
162.
Tucker R. Ensure pregnant travellers know the risks. Practice Nurse. 1999;18:458–66.
163.
Rose SR. Pregnancy and travel. Emergency Medicine Clinics of North America. 1997;15:93–111. [PubMed: 9056572]
164.
Baron TH, Ramirez B, Richter JE. Gastrointestinal motility disorders during pregnancy. Annals of Internal Medicine. 1993;118:366–75. [PubMed: 8257464]
165.
Weigel RM, Weigel MM. Nausea and vomiting of early pregnancy and pregnancy outcome. A meta-analytical review. British Journal of Obstetrics and Gynaecology. 1989;96:1312–8. [PubMed: 2611170]
166.
Whitehead SA, Andrews PL, Chamberlain GV. Characterisation of nausea and vomiting in early pregnancy: a survey of 1000 women. Journal of Obstetrics and Gynaecology. 1992;12:364–9.
167.
Gadsby R, Barnie-Adshead AM, Jagger C. A prospective study of nausea and vomiting during pregnancy. British Journal of General Practice. 1993;43:245–8. [PMC free article: PMC1372422] [PubMed: 8373648]
168.
Feldman M. Nausea and vomiting, Gastrointestinal disease. Sleisenger MH, Fordtran JS, editors. Philadelphia: WB Saunders; 1989. pp. 229–31.
169.
Klebanoff MA, Mills JL. Is vomiting during pregnancy teratogenic? British Medical Journal. 1986;292:724–6. [PMC free article: PMC1339779] [PubMed: 3082411]
170.
Smith C, Crowther C, Beilby J, Dandeaux J. The impact of nausea and vomiting on women: a burden of early pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2000;40:397–401. [PubMed: 11194422]
171.
Attard CL, Kohli MA, Coleman S, Bradley C, Hux M, Atanackovic G, et al. The burden of illness of severe nausea and vomiting of pregnancy in the United States. American Journal of Obstetrics and Gynecology. 2002;186:S220–7. [PubMed: 12011890]
172.
Vutyavanich T, Kraisarin T, Ruangsri R. Ginger for nausea and vomiting in pregnancy: randomized, double-masked, placebo-controlled trial. Obstetrics and Gynecology. 2001;97:577–82. [PubMed: 11275030]
173.
Jewell D, Young G. Interventions for nausea and vomiting in early pregnancy. Cochrane Database of Systematic Reviews. 2001;(2) [PubMed: 20824826]
174.
Murphy PA. Alternative therapies for nausea and vomiting of pregnancy. Obstetrics and Gynecology. 1998;91:149–55. [PubMed: 9464741]
175.
Keating A, Chez RA. Ginger syrup as an antiemetic in early pregnancy. Alternative Therapies in Health and Medicine. 2002;8:89–91. [PubMed: 12233808]
176.
Vickers AJ. Can acupuncture have specific effects on health? A systematic review of acupuncture antiemesis trials. Journal of the Royal Society of Medicine. 1996;89:303–11. [PMC free article: PMC1295813] [PubMed: 8758186]
177.
Norheim AJ, Pedersen EJ, Fonnebo V, Berge L. Acupressure treatment of morning sickness in pregnancy. A randomised, double-blind, placebo-controlled study. Scandinavian Journal of Primary Health Care. 2001;19:43–7. [PubMed: 11303547]
178.
Knight B, Mudge C, Openshaw S, White A, Hart A. Effect of acupuncture on nausea of pregnancy: a randomized, controlled trial. Obstetrics and Gynecology. 2001;97:184–8. [PubMed: 11165579]
179.
Werntoft E, Dykes AK. Effect of acupressure on nausea and vomiting during pregnancy: a randomized, placebo-controlled, pilot study. Journal of Reproductive Medicine. 2001;46:835–9. [PubMed: 11584487]
180.
Smith C, Crowther C, Beilby J. Acupuncture to treat nausea and vomiting in early pregnancy: a randomized controlled trial. Birth. 2002;29:1–9. [PubMed: 11843784]
181.
Smith C, Crowther C, Beilby J. Pregnancy outcome following womens’ participation in a randomised controlled trial of acupuncture to treat nausea and vomiting in early pregnancy. Complementary Therapies in Medicine. 2002;10:78–83. [PubMed: 12481955]
182.
Mazzotta P, Magee LA. A risk–benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy. Drugs. 2000;59:781–800. [PubMed: 10804035]
183.
Magee LA, Mazzotta P, Koren G. Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP) American Journal of Obstetrics and Gynecology. 2002;186:S256–61. [PubMed: 12011897]
184.
Marrero JM, Goggin PM, Caestecker JS. Determinants of pregnancy heartburn. British Journal of Obstetrics and Gynaecology. 1992;99:731–4. [PubMed: 1420011]
185.
Knudsen A, Lebech M, Hansen M. Upper gastrointestinal symptoms in the third trimester of the normal pregnancy. European Journal of Obstetrics Gynecology and Reproductive Biology. 1995;60:29–33. [PubMed: 7635226]
186.
Bainbridge ET, Temple JG, Nicholas SP, Newton JR, Boriah V. Symptomatic gastro-esophageal reflux in pregnancy. A comparative study of white Europeans and Asians in Birmingham. British Journal of Clinical Practice. 1983;37:53–7. [PubMed: 6860538]
187.
Shaw RW. Randomized controlled trial of Syn-Ergel and an active placebo in the treatment of heartburn of pregnancy. Journal of International Medical Research. 1978;6:147–51. [PubMed: 344087]
188.
Lang GD, Dougall A. Comparative study of Algicon suspension and magnesium trisilicate mixture in the treatment of reflux dyspepsia of pregnancy. British Journal of Clinical Practice. 1989;66:48–51. [PubMed: 2556175]
189.
Association of the British Pharmaceutical Industry. ABPI Compendium of Data Sheets and Summaries of Product Characteristics, Medicines Compendium. London: Datapharm Communications; 2001.
190.
Atlay RD, Parkinson DJ, Entwistle GD, Weekes AR. Treating heartburn in pregnancy: comparison of acid and alkali mixtures. British Medical Journal. 1978;2:919–20. [PMC free article: PMC1608055] [PubMed: 361152]
191.
Rayburn W, Liles E, Christensen H, Robinson M. Antacids vs. antacids plus non-prescription ranitidine for heartburn during pregnancy. International Journal of Gynaecology and Obstetrics. 1999;66:35–7. [PubMed: 10458549]
192.
Larson JD, Patatanian E, Miner PB Jr, Rayburn WF, Robinson MG. Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy. Obstetrics and Gynecology. 1997;90:83–7. [PubMed: 9207819]
193.
Magee LA, Inocencion G, Kamboj L, Rosetti F, Koren G. Safety of first trimester exposure to histamine H2 blockers. A prospective cohort study. Digestive Diseases and Sciences. 1996;41:1145–9. [PubMed: 8654145]
194.
Nikfar S, Abdollahi M, Moretti ME, Magee LA, Koren G. Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis. Digestive Diseases and Sciences. 2002;47:1526–9. [PubMed: 12141812]
195.
Meyer LC, Peacock JL, Bland JM, Anderson HR. Symptoms and health problems in pregnancy: their association with social factors, smoking, alcohol, caffeine and attitude to pregnancy. Paediatric and Perinatal Epidemiology. 1994;8:145–55. [PubMed: 8047482]
196.
Jewell DJ, Young G. Interventions for treating constipation in pregnancy. Cochrane Database of Systematic Reviews. 2003;(1) [PubMed: 10796250]
197.
Abramowitz L, Sobhani I, Benifla JL, Vuagnat A, Darai E, Mignon M, et al. Anal fissure and thrombosed external hemorrhoids before and after delivery. Diseases of the Colon and Rectum. 2002;45:650–5. [PubMed: 12004215]
198.
Wijayanegara H, Mose JC, Achmad L, Sobarna R, Permadi W. A clinical trial of hydroxyethylrutosides in the treatment of haemorrhoids of pregnancy. Journal of International Medical Research. 1992;20:54–60. [PubMed: 1568520]
199.
Buckshee K, Takkar D, Aggarwal N. Micronized flavonoid therapy in internal hemorrhoids of pregnancy. International Journal of Gynecology and Obstetrics. 1997;57:145–51. [PubMed: 9184951]
200.
Saleeby RG Jr, Rosen L, Stasik JJ, Riether RD, Sheets J, Khubchandani IT. Hemorrhoidectomy during pregnancy: risk or relief? Diseases of the Colon and Rectum. 1991;3445:260–1. [PubMed: 1999133]
201.
Thaler E, Huch R, Huch A, Zimmermann R. Compression stockings prophylaxis of emergent varicose veins in pregnancy: A prospective randomised controlled study. Swiss Medical Weekly. 2001;131:659–62. [PubMed: 11835115]
202.
Gulmezoglu AM. Interventions for trichomoniasis in pregnancy. Cochrane Database of Systematic Reviews. 2002;(3):CD000220. [PubMed: 12137609]
203.
French JI, McGregor JA, Draper D, Parker R, McFee J. Gestational bleeding, bacterial vaginosis, and common reproductive tract infections: risk for preterm birth and benefit of treatment. Obstetrics and Gynecology. 1999;93:715–24. [PubMed: 10912974]
204.
Young GL, Jewell MD. Topical treatment for vaginal candidiasis in pregnancy. Cochrane Database of Systematic Reviews. 2001;(2) [PubMed: 11687074]
205.
Greenwood CJ, Stainton MC. Back pain/discomfort in pregnancy: invisible and forgotten. Journal of Perinatal Education. 2001;10:1–12. [PMC free article: PMC1595051] [PubMed: 17273235]
206.
Kristiansson P, Svardsudd K, von Schoultz B. Back pain during pregnancy: A prospective study. Spine. 1996;21:702–9. [PubMed: 8882692]
207.
Ostgaard HC, Andersson GBJ, Karlsson K. Prevalence of back pain in pregnancy. Spine. 1991;16:549–52. [PubMed: 1828912]
208.
Fast A, Shapiro D, Ducommun EJ, Friedman LW, Bouklas T, Floman Y. Low-back pain in pregnancy. Spine. 1987;12:368–71. [PubMed: 2956698]
209.
Stapleton DB, MacLennan AH, Kristiansson P. The prevalence of recalled low back pain during and after pregnancy: A South Australian population survey. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2002;42:482–5. [PubMed: 12495090]
210.
Mantle MJ, Greenwood RM, Currey HL. Backache in pregnancy. Rheumatology and Rehabilitation. 1977;16:95–101. [PubMed: 141093]
211.
Young G, Jewell D. Interventions for preventing and treating pelvic and back pain in pregnancy. Cochrane Database of Systematic Reviews. 2003;(1) [PubMed: 11869592]
212.
Field T, Hernandez-Reif M, Hart S, Theakston H, Schanberg S, Kuhn C. Pregnant women benefit from massage therapy. Journal of Psychosomatic Obstetrics and Gynecology. 1999;20:31–8. [PubMed: 10212885]
213.
Ostgaard HC, Zetherstrom G, Roos-Hansson E, Svanberg B. Reduction of back and posterior pelvic pain in pregnancy. Spine. 1994;19:894–900. [PubMed: 8009346]
214.
Noren L, Ostgaard S, Nielsen TF, Ostgaard HC. Reduction of sick leave for lumbar back and posterior pelvic pain in pregnancy. Spine. 1997;22:2157–60. [PubMed: 9322326]
215.
Tesio L, Raschi A, Meroni M. Autotraction treatment for low-back pain in pregnancy: A pilot study. Clinical Rehabilitation. 1994;8:314–19.
216.
Guadagnino MR III. Spinal manipulative therapy for 12 pregnant patients suffering from low back pain. Chiropractic Technique. 1999;11:108–11.
217.
McIntyre IN, Broadhurst NA. Effective treatment of low back pain in pregnancy. Australian Family Physician. 1996;25:S65–7. [PubMed: 8854409]
218.
Requejo SM, Barnes R, Kulig K, Landel R, Gonzalez S. The use of a modified classification system in the treatment of low back pain during pregnancy: A case report. Journal of Orthopaedic and Sports Physical Therapy. 2002;32:318–26. [PubMed: 12113466]
219.
Owens K, Pearson A, Mason G. Symphysis pubis dysfunction: a cause of significant obstetric morbidity. European Journal of Obstetrics Gynecology and Reproductive Biology. 2002;105:143–6. [PubMed: 12381476]
220.
Fry D, Hay-Smith J, Hough J, McIntosh J, Polden M, Shepherd J, et al. National clinic guideline for the care of women with symphysis pubis dysfunction. Midwives. 1997;110:172–3. [PubMed: 9256762]
221.
Gould JS, Wissinger HA. Carpal tunnel syndrome in pregnancy. Southern Medical Journal. 1978;71:144–5,154. [PubMed: 622622]
222.
Voitk AJ, Mueller JC, Farlinger DE, Johnston RU. Carpal tunnel syndrome in pregnancy. Canadian Medical Association Journal. 1983;128:277–81. [PMC free article: PMC1874761] [PubMed: 6821784]
223.
Padua L, Aprile I, Caliandro P, Carboni T, Meloni A, Massi S, et al. Symptoms and neurophysiological picture of carpal tunnel syndrome in pregnancy. Clinical Neurophysiology. 2001;112:1946–51. [PubMed: 11595156]
224.
Courts RB. Splinting for symptoms of carpal tunnel syndrome during pregnancy. Journal of Hand Therapy. 1995;8:31–4. [PubMed: 7742893]
225.
Ekman-Ordeberg G, Salgeback S, Ordeberg G. Carpal tunnel syndrome in pregnancy. A prospective study. Acta Obstetricia et Gynecologica Scandinavica. 1987;66:233–5. [PubMed: 3661130]
226.
Stahl S, Blumenfeld Z, Yarnitsky D. Carpal tunnel syndrome in pregnancy: Indications for early surgery. Journal of the Neurological Sciences. 1996;136:182–4. [PubMed: 8815170]
227.
Dawes MG, Grudzinskas JG. Repeated measurement of maternal weight during pregnancy. Is this a useful practice? British Journal of Obstetrics and Gynaecology. 1991;98:189–94. [PubMed: 1805806]
228.
National Academy of Sciences, Institute of Medicine, Food and Nutrition Board, Committee on Nutritional Status During Pregnancy and Lactation, Subcommittee on Dietary Intake and Nutrient Supplements During Pregnancy, Subcommittee on Nutritional Status and Weight Gain During Pregnancy. Nutrition during pregnancy. Washington DC: National Academy Press; 1990.
229.
Siega-Riz AM, Adair LS, Hobel CJ. Maternal underweight status and inadequate rate of weight gain during the third trimester of pregnancy increases the risk of preterm delivery. Journal of Nutrition. 1996;126:146–53. [PubMed: 8558295]
230.
Bergmann MM, Flagg EW, Miracle-McMahill HL, Boeing H. Energy intake and net weight gain in pregnant women according to body mass index (BMI) status. International Journal of Obesity and Related Metabolic Disorders. 1997;21:1010–7. [PubMed: 9368824]
231.
Alexander JM, Grant AM, Campbell MJ. Randomised controlled trial of breast shells and Hoffman’s exercises for inverted and non-protractile nipples. British Medical Journal. 1992;304:1030–2. [PMC free article: PMC1881748] [PubMed: 1586788]
232.
Pattinson RE. Pelvimetry for fetal cephalic presentations at term. Cochrane Database of Systematic Reviews. 2001;(3):2001. [PubMed: 10796162]
233.
Lenihan JP Jr. Relationship of antepartum pelvic examinations to premature rupture of the membranes. Obstetrics and Gynecology. 1984;83:33–7. [PubMed: 6691015]
234.
Goffinet F. [Ovarian cyst and pregnancy]. [French] Journal de Gynecologie, Obstetrique et Biologie de la Reproduction2001304S100–8. [PubMed: 11917371]
235.
O’Donovan P, Gupta JK, Savage J, Thornton JG, Lilford RJ. Is routine antenatal booking vaginal examination necessary for reasons other than cervical cytology if ultrasound examination is planned? British Journal of Obstetrics and Gynaecology. 1988;95:556–9. [PubMed: 3291933]
236.
World Health Organization. Female genital mutilation, WHO Information Fact Sheet No. 241. Geneva: World Health Organization; 2000.
237.
British Medical Association. Female genital mutilation: caring for patients and child protection. London: BMA; 2001.
238.
Momoh C, Ladhani S, Lochrie DP, Rymer J. Female genital mutilation: Analysis of the first twelve months of a southeast London specialist clinic. BJOG. 2001;108:186–91. [PubMed: 11236119]
239.
World Health Organization. A systematic review of the health complications of female genital mutilation including sequelae in childbirth. Geneva: WHO; 2000.
240.
McCaffrey M, Jankowska A, Gordon H. Management of female genital mutilation: The Northwick Park Hospital experience. British Journal of Obstetrics and Gynaecology. 1995;102:787–90. [PubMed: 7547734]
241.
Jordan JA. Female genital mutilation (female circumcision) British Journal of Obstetrics and Gynaecology. 1994;101:94–5. [PubMed: 8305404]
242.
British Medical Association. Domestic violence: a health care issue? London: BMA; 1998.
243.
Tjaden P, Thoennes N. Full report of the prevalence, incidence, and consequences of violence against women. Findings from the National Violence Against Women Survey, NCJ. Vol. 183781. Washington DC: US Department of Justice, National Institute of Justice; 2000. pp. 1–61.
244.
Canadian Centre for Justice Statistics. Family violence in Canada: A statistical profile 2002. Ottawa: Statistics Canada; 2002. [Accessed 20 August 2003]. pp. 85–224-XIE. [ www​.statcan.ca/english​/IPS/Data/85-224-XIE.htm]
245.
Jones AS, Carlson Gielen A, Campbell JC. Annual and lifetimes prevalence of partner abuse in a sample of female HMO enrollees. Women’s Health Issues. 1999;9:295–305.
246.
Ballard TJ, Saltzman LE, Gazmararian JA, Spitz AM, Lazorick S, Marks JS. Violence during pregnancy: measurement issues. American Journal of Public Health. 1998;88:274–6. [PMC free article: PMC1508190] [PubMed: 9491021]
247.
Royal College of Obstetricians and Gynaecologists. Violence against women. London: RCOG Press; 1997.
248.
Johnson JK, Haider F, Ellis K, Hay DM, Lindow SW. The prevalence of domestic violence in pregnant women. BJOG. 2003;110:272–5. [PubMed: 12628266]
249.
Newberger EH, Barkan SE, Lieberman ES, McCormick MC, Yllo K, Gary LT, et al. Abuse of pregnant women and adverse birth outcome: current knowledge and implications for practice. Journal of the American Medical Association. 1992;267:2370–2. [PubMed: 1564780]
250.
Murphy CC, Schei B, Myhr TL, Du MJ. Abuse: a risk factor for low birth weight? A systematic review and meta-analysis. [see comments] Canadian Medical Association Journal. 2001;164:1567–72. [PMC free article: PMC81110] [PubMed: 11402794]
251.
Cokkinides VE, Coker AL, Sanderson M, Addy C, Bethea L. Physical violence during pregnancy: maternal complications and birth outcomes. Obstetrics and Gynecology. 1999;93:661–6. [PubMed: 10912963]
252.
Janssen PA, Holt VL, Sugg NK, Emanuel I, Critchlow CM, Henderson AD. Intimate partner violence and adverse pregnancy outcomes: A population-based study. American Journal of Obstetrics and Gynecology. 2003;188:1341–7. [PubMed: 12748509]
253.
Royal College of Midwives. Domestic abuse in pregnancy. London: RCM; 1999.
254.
Royal College of Psychiatrists. Domestic violence. CR102. London: RCPsych; 2002.
255.
Wathen CN, MacMillan HL. Interventions for violence against women. Scientific review. JAMA. 2003;289:589–600. [PubMed: 12578492]
256.
Ramsay J, Richardson J, Carter YH, Davidson LL, Feder G. Should health professionals screen women for domestic violence? Systematic review. British Medical Journal. 2002;325:314–18. [PMC free article: PMC117773] [PubMed: 12169509]
257.
Cann K, Withnell S, Shakespeare J, Doll H, Thomas J. Domestic violence: a comparative survey of levels of detection, knowledge, and attitudes in healthcare workers. Public Health. 2001;115:89–95. [PubMed: 11406772]
258.
Department of Health. Domestic violence: A resource manual for health care professionals. London: Department of Health; 2000.
259.
Wilson LM, Reid AJ, Midmer DK, Biringer A, Carroll JC, Stewart DE. Antenatal psychosocial risk factors associated with adverse postpartum family outcomes. Canadian Medical Association Journal. 1996;154:785–99. [PMC free article: PMC1487795] [PubMed: 8634957]
260.
Perkin MR, Bland JM. The effect of anxiety and depression during pregnancy on obstetric complications. British Journal of Obstetrics and Gynaecology. 1993;100:629–34. [PubMed: 8369244]
261.
Dayan J, Creveuil C, Herlicoviez M. Role of anxiety and depression in the onset of spontaneous preterm labor. American Journal of Epidemiology. 2002;155:293–301. [PubMed: 11836191]
262.
Lundy BL, Jones NA, Field T. Prenatal depression effects on neonates. Infant Behavior and Development. 1999;22:119–29.
263.
Murray D, Cox JL. Screening for depression during pregnancy with the Edinburgh Depression Scale (EPDS) Journal of Reproductive and Infant Psychology. 1990;8:99–107.
264.
Bolton HL, Hughes PM, Turton P. Incidence and demographic correlates of depressive symptoms during pregnancy in an inner London population. Journal of Psychosomatic Obstetrics and Gynecology. 1998;19:202–9. [PubMed: 9929846]
265.
Evans J, Heron J, Francomb H, Oke S, Golding J. Cohort study of depressed mood during pregnancy and after childbirth. British Medical Journal. 2001;323:257–60. [PMC free article: PMC35345] [PubMed: 11485953]
266.
Austin M-P, Lumley J. Antenatal screening for postnatal depression: a systematic review. Acta Psychiatrica Scandinavica. 2003;107:10–17. [PubMed: 12558536]
267.
Hayes BA, Muller R, Bradley BS. Perinatal depression: a randomized controlled trial of an antenatal education intervention for primiparas. Birth. 2001;28:28–35. [PubMed: 11264626]
268.
Brugha TS, Wheatly S, Taub NA, Culverwell A, Friedman T, Kirwan P. Pragmatic randomized trial of an antenatal intervention to prevent post-natal depression by reducing psychosocial risk factors. Psychological Medicine. 2000;30:1273–81. [PubMed: 11097068]
269.
Hytten F. Blood volume changes in normal pregnancy. Clinical Haematology. 1985;14:601–12. [PubMed: 4075604]
270.
Ramsey M, James D, Steer P, Weiner C, Gornik B. Normal values in pregnancy. 2nd ed. London: WB Saunders; 2000.
271.
Steer P, Alam MA, Wadsworth J, Welch A. Relation between maternal haemoglobin concentration and birth weight in different ethnic groups. British Medical Journal. 1995;310:489–91. [PMC free article: PMC2548871] [PubMed: 7888886]
272.
Zhou LM, Yang WW, Hua JZ, Deng CQ, Tao X, Stoltzfus RJ. Relation of hemoglobin measured at different times in pregnancy to preterm birth and low birth weight in Shanghai, China. American Journal of Epidemiology. 1998;148:998–1006. [PubMed: 9829872]
273.
Breymann C. Iron supplementation during pregnancy. Fetal and Maternal Medicine Review. 2002;13:1–29.
274.
Cuervo LG, Mahomed K. Treatments for iron deficiency anaemia during pregnancy. Cochrane Database of Systematic Reviews. 2001;(2) [PubMed: 11406073]
275.
Davies SC, Cronin E, Gill M, Greengross P, Hickman M, Normand C. Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research. Health Technology Assessment. 2000;4:1–119. [PubMed: 10840658]
276.
Modell B, Harris R, Lane B, Khan M, Darlison M, Petrou M, et al. Informed choice in genetic screening for thalassaemia during pregnancy: audit from a national confidential inquiry. British Medical Journal. 2000;320:337–41. [PMC free article: PMC27278] [PubMed: 10657326]
277.
Modell B, Petrou M, Layton M, Varnavides L, Slater C, Ward RH, et al. Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: the first 20 years. [see comments] British Medical Journal. 1997;315:779–84. [PMC free article: PMC2127541] [PubMed: 9345170]
278.
Department of Health. Sickle cell, thalassaemia and other haemoglobinopathies, Report of a Working Party of the Standing Medical Advisory Committee. London: DoH; 1999.
279.
Zeuner D, Ades AE, Karnon J, Brown JE, Dezateux C, Anionwu EN. Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis. Health Technology Assessment. 1999;3(11):1–186. [PubMed: 10516927]
280.
Streetly A. A national screening policy for sickle cell disease and thalassaemia major for the United Kingdom. Questions are left after two evidence based reports. British Medical Journal. 2000;320:1353–4. [PMC free article: PMC1118032] [PubMed: 10818007]
281.
Aspinall PJ, Dyson SM, Anionwu EN. The feasibility of using ethnicity as a primary tool for antenatal selective screening for sickle cell disorders: pointers from the research evidence. Social Science and Medicine. 2003;56:285–97. [PubMed: 12473314]
282.
Petrou M, Brugiatelli M, Ward RHT, Modell B. Factors affecting the uptake of prenatal diagnosis for sickle cell disease. Journal of Medical Genetics. 1992;29:820–3. [PMC free article: PMC1016180] [PubMed: 1453435]
283.
Modell B, Ward RH, Fairweather DV. Effect of introducing antenatal diagnosis on reproductive behaviour of families at risk for thalassaemia major. British Medical Journal. 1980;280:1347–50. [PMC free article: PMC1601817] [PubMed: 7388536]
284.
Ahmed S, Saleem M, Sultana N, Raashid Y, Waqar A, Anwar M, et al. Prenatal diagnosis of beta-thalassaemia in Pakistan: experience in a Muslim country. Prenatal Diagnosis. 2000;20:378–83. [PubMed: 10820404]
285.
UK Blood Transfusion Services. Guidelines for the Blood Transfusion Service. 6th ed. London: TSO; 2002. [Accessed 20 August 2003]. [ www​.transfusionguidelines​.org.uk/uk_guidelines/ukbts6_$01​.html]
286.
Whittle MJ. Antenatal serology testing in pregnancy. British Journal of Obstetrics and Gynaecology. 1996;103:195–6. [PubMed: 8630299]
287.
Brouwers HA, Overbeeke MA, van EI, Schaasberg W, Alsbach GP, van der HC, et al. What is the best predictor of the severity of ABO-haemolytic disease of the newborn? Lancet. 1988;2:641–4. [PubMed: 2901516]
288.
Mollison PL, Engelfriet CP, Contreras M. Haemolytic disease of the fetus and newborn. Blood transfusion in clinical medicine. Oxford: Blackwell Science; 1997. pp. 390–424.
289.
Shanwell A, Sallander S, Bremme K, Westgren M. Clinical evaluation of a solid-phase test for red cell antibody screening of pregnant women. Transfusion. 1999;39:26–31. [PubMed: 9920163]
290.
Filbey D, Hanson U, Wesstrom G. The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: a 12 year study in central Sweden. Acta Obstetrica et Gynecologica Scandinavica. 1995;74:687–92. [PubMed: 7572101]
291.
British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for blood grouping and red cell antibody testing during pregnancy. Transfusion Medicine. 1996;6:71–4. [PubMed: 8696452]
292.
National Institute for Clinical Excellence. Technology Appraisal Guidance, No. 41. London: National Institute for Clinical Excellence; 2002. [Accessed 20 August 2003]. Guidance on the use of routine antenatal anti-D prophylaxis for RhD-negative women. [ www​.nice.org.uk/pdf/prophylaxisFinalguidance.pdf]
293.
Royal College of Obstetricians and Gynaecologists. Ultrasound screening for fetal abnormalities: report of the RCOG working party. London: RCOG Press; 1997.
294.
Jepsen RG, Forbes CA, Sowden AJ, Lewis RA. Increasing informed uptake and non-uptake of screening: evidence from a systematic review. Health Expectations. 2001;4:116–26. [PubMed: 11359542]
295.
Department of Health, social Services and Public Safety, Northern Ireland, National Assembly for Wales, Scottish Executive, Department of Health. Second report of the UK National Screening Committee. London: DoH; 2000. [Accessed 21 August 2003]. [ www​.nsc.nhs.uk/pdfs/secondreport.pdf]
296.
Royal College of Obstetricians and Gynaecologists. Report of the RCOG working party on biochemical markers and the detection of Down’s syndrome. London: Royal College of Obstetricians and Gynaecologists; 1993.
297.
Bricker L, Garcia J, Henderson J, Mugford M, Neilson J, Roberts T, et al. Ultrasound screening in pregnancy: a systematic review of the clinical effectiveness, cost-effectiveness and women’s views. Health Technology Assessment. 2000;4:1–193. [PubMed: 11070816]
298.
Williamson P, Alberman E, Rodeck C, Fiddler M, Church S, Harris R. Antecedent circumstances surrounding neural tube defect births in 1990–1991. British Journal of Obstetrics and Gynaecology. 1997;104:51–6. [PubMed: 8988697]
299.
Saari-Kemppainen A, Karjalainen O, Ylostalo P, Heinonen OP. Fetal anomalies in a controlled one-stage ultrasound screening trial. A report from the Helsinki Ultrasound Trial. Journal of Perinatal Medicine. 1994;22(4):279–289. [PubMed: 7877064]
300.
Whitlow BJ, Chatzipapas IK, Lazanakis ML, Kadir RA, Economides DL. The value of sonography in early pregnancy for the detection of fetal abnormalities in an unselected population. British Journal of Obstetrics and Gynaecology. 1999;106:929–36. [PubMed: 10492104]
301.
National Assembly for Wales/Velindre NHS Trust Antenatal Project Team Steering Board. Choices: Recommendations for the provision and management of antenatal screening in Wales. Cardiff: Velindre NHS Trust; Mar, 2002. [Accessed 21 August 2003]. [ www​.velindretr.wales​.nhs.uk/antenatal/consult_doc/choices​.pdf]
302.
Royal College of Obstetricians and Gynaecologists. Routine ultrasound screening in pregnancy, protocols, standards and training, Supplement to ultrasound screening for fetal abnormalities. Report of the RCOG Working Party. London: RCOG Press; 2000.
303.
Office for National Statistics. Child health statistics. London: National Statistics; 2000. pp. 1–26.
304.
Noble J. Natural history of Down’s syndrome: a brief review for those involved in antenatal screening. Journal of Medical Screening. 1998;5:172–7. [PubMed: 9934646]
305.
Marteau TM, Dormandy E. Facilitating informed choice in prenatal testing: how well are we doing? American Journal of Medical Genetics. 2001;106:185–90. [PubMed: 11778978]
306.
Smith DK, Shaw RW, Marteau TM. Informed consent to undergo serum screening for Down’s syndrome: the gap between policy and practice. British Medical Journal. 1994;309:776. [PMC free article: PMC2540988] [PubMed: 7950565]
307.
Royal College of Obstetricians and Gynaecologists. Amniocentesis, Guideline No. 8. London: Royal College of Obstetricians and Gynaecologists; 2000.
308.
Deeks JJ. Systematic reviews of evaluations of diagnostic and screening tests. British Medical Journal. 2001;323:157–62. [PMC free article: PMC1120791] [PubMed: 11463691]
309.
Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA. 1999;282:1061–6. [PubMed: 10493205]
310.
Hook EB. Spontaneous deaths of fetuses with chromosomal abnormalities diagnosed prenatally. New England Journal of Medicine. 1978;299:1036–8. [PubMed: 151805]
311.
Morris JK, Mutton DE, Alberman E. Revised estimates of the maternal age specific live birth prevalence of Down’s syndrome. Journal of Medical Screening. 2002;9:2–6. [PubMed: 11943789]
312.
Paranjothy S, Thomas J. National Sentinel Caesarean Section Audit. MIDIRS Midwifery Digest. 2001;11:S13–15.
313.
Wald NJ, Huttly WJ, Hennessy CF. Down’s syndrome screening in the UK in 1998. Lancet. 1999;354:1264. [PubMed: 10520640]
314.
Youings S, Gregson N, Jacobs P. The efficacy of maternal age screening for Down’s syndrome in Wessex. Prenatal Diagnosis. 1991;11:419–25. [PubMed: 1836564]
315.
Smith-Bindman R, Hosmer W, Feldstein VA, Deeks JJ, Goldberg JD. Second-trimester ultrasound to detect fetuses with Down’s syndrome. JAMA. 2001;285:1044–55. [PubMed: 11209176]
316.
Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down’s syndrome: the results of the serum, urine and ultrasound screening study (SURUSS) Health Technology Assessment. 2003;7:1–88. [PubMed: 12709291]
317.
Bindra R, Heath V, Nicolaides KH. Screening for chromosomal defects by fetal nuchal translucency at 11 to 14 weeks. Clinical Obstetrics and Gynecology. 2002;45:661–70. [PubMed: 12370606]
318.
Niemimaa M, Suonpaa M, Perheentupa A, Seppala M, Heinonen S, Laitinen P, et al. Evaluation of first trimester maternal serum and ultrasound screening for Down’s syndrome in Eastern and Northern Finland. European Journal of Human Genetics. 2001;9:404–8. [PubMed: 11436120]
319.
Wald NJ, Kennard A, Hackshaw A, McGuire A. Antenatal screening for Down’s syndrome. Health Technology Assessment. 1998;2:1–112. [PubMed: 9561893]
320.
Conde-Agudelo A, Kafury-Goeta AC. Triple-marker test as screening for Down syndrome: a meta-analysis. Obstetrical and Gynecological Survey. 1998;53:369–76. [PubMed: 9618713]
321.
Wald NJ, Huttly WJ, Hackshaw AK. Antenatal screening for Down’s syndrome with the quadruple test. Lancet. 2003;361:835–6. [PubMed: 12642052]
322.
Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. BJOG. 2003;110:281–6. [PubMed: 12628268]
323.
Alfirevic Z, Gosden C, Neilson JP. Chorion villus sampling versus amniocentesis for prenatal diagnosis. Cochrane Database of Systematic Reviews. 1998;(4):1–8. [PubMed: 17636578]
324.
Alfirevic Z. Early amniocentesis versus transabdominal chorion villus sampling. Cochrane Database of Systematic Reviews. 2000;(1):1. [PubMed: 10796116]
325.
Tercyak KP, Johnson SB, Roberts SF, Cruz AC. Psychological response to prenatal genetic counseling and amniocentesis. Patient Education and Counseling. 2001;43:73–84. [PubMed: 11311841]
326.
Green JM. Women’s experiences of prenatal screening and diagnosis, Prenatal diagnosis: the human side. Abramsky L, Chapple J, editors. London: Chapman and Hall; 1994. pp. 37–53.
327.
Liu S, Joseph KS, Kramer MS, Allen AC, Sauve R, Rusen ID, et al. Relationship of prenatal diagnosis and pregnancy termination to overall infant mortality in Canada. JAMA. 2002;287:1561–7. [PubMed: 11911759]
328.
Whalley P. Bacteriuria of pregnancy. American Journal of Obstetrics and Gynecology. 1967;97:723–38. [PubMed: 5335276]
329.
Little PJ. The incidence of urinary infection in 5000 pregnant women. Lancet. 1966;2:925–8. [PubMed: 4162367]
330.
Campbell-Brown M, McFadyen IR, Seal DV, Stephenson ML. Is screening for bacteriuria in pregnancy worth while? British Medical Journal. 1987;294:1579–82. [PMC free article: PMC1246728] [PubMed: 3113538]
331.
Foley ME, Farquharson R, Stronge JM. Is screening for bacteriuria in pregnancy worthwhile? British Medical Journal. 1987;295:270. [PMC free article: PMC1247109] [PubMed: 3115406]
332.
LeBlanc AL, McGanity WJ. The impact of bacteriuria in pregnancy: a survey of 1300 pregnant patients. Biologie Medicale. 1964;22:336–47. [PubMed: 14157822]
333.
Kincaid-Smith P, Bullen M. Bacteriuria in pregnancy. Lancet. 1965:395–9. [PubMed: 14238090]
334.
Thomsen AC, Morup L, Hansen KB. Antibiotic elimination of group-B streptococci in urine in prevention of preterm labour. Lancet. 1987:591–3. [PubMed: 2881132]
335.
Elder HA, Santamarina BAG, Smith S, Kass EH. The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. American Journal of Obstetrics and Gynecology. 1971;111:441–62. [PubMed: 4937729]
336.
Gold EM, Traub FB, Daichman I, Terris M. Asymptomatic bacteriuria during pregnancy. Obstetrics and Gynecology. 1966;27:206–9. [PubMed: 5325600]
337.
Mulla N. Bacteriuria in Pregnancy. Obstetrics and Gynecology. 1960;16:89–92. [PubMed: 14425118]
338.
Savage WE, Hajj SN, Kass EH. Demographic and prognostic characteristics of bacteriuria in pregnancy. Medicine. 1967;46:385–407. [PubMed: 4864339]
339.
Mittendorf R, Williams MA, Kass EH. Prevention of preterm delivery and low birth weight associated with asymptomatic bacteriuria. Clinical Infectious Diseases. 1992;14:927–32. [PubMed: 1533541]
340.
Patterson TF, Andriole VT. Bacteriuria in pregnancy. Infectious Disease Clinics of North America. 1987;1:807–22. [PubMed: 3333660]
341.
Screening for asymptomatic bacteriuria hematuria and proteinuria, The US Preventive Services Task Force. American Family Physician. 1990;42:389–95. [PubMed: 2200247]
342.
Etherington IJ, James DK. Reagent strip testing of antenatal urine specimens for infection. British Journal of Obstetrics and Gynaecology. 1993;100:806–8. [PubMed: 8217998]
343.
Shelton SD, Boggess KA, Kirvan K, Sedor F, Herbert WN. Urinary interleukin-8 with asymptomatic bacteriuria in pregnancy. Obstetrics and Gynecology. 2001;97:583–6. [PubMed: 11275031]
344.
Millar L, Debuque L, Leialoha C, Grandinetti A, Killeen J. Rapid enzymatic urine screening test to detect bacteriuria in pregnancy. Obstetrics and Gynecology. 2000;95:601–4. [PubMed: 10725497]
345.
McNair RD, MacDonald SR, Dooley SL, Peterson LR. Evaluation of the centrifuged and Gram-stained smear, urinalysis, and reagent strip testing to detect asymptomatic bacteriuria in obstetric patients. American Journal of Obstetrics and Gynecology. 2000;182:1076–9. [PubMed: 10819832]
346.
Robertson AW, Duff P. The nitrite and leukocyte esterase tests for the evaluation of asymptomatic bacteriuria in obstetric patients. Obstetrics and Gynecology. 1988;71:878–81. [PubMed: 3285267]
347.
Bachman JW, Heise RH, Naessens JM, Timmerman MG. A study of various tests to detect asymptomatic urinary tract infections in an obstetric population. JAMA. 1993;270:1971–4. [PubMed: 8411555]
348.
Tincello DG, Richmond DH. Evaluation of reagent strips in detecting asymptomatic bacteriuria in early pregnancy: prospective case series. British Medical Journal. 1998;316:435–7. [PMC free article: PMC2665586] [PubMed: 9492667]
349.
Abyad A. Screening for asymptomatic bacteriuria in pregnancy: urinalysis vs. urine culture. Journal of Family Practice. 1991;33:471–4. [PubMed: 1940814]
350.
Graninger W, Fleischmann D, Schneeweiss B, Aram L, Stockenhuber F. Rapid screening for bacteriuria in pregnancy. Infection. 1992;20:9–11. [PubMed: 1563815]
351.
Smaill F. Antibiotic treatment for symptomatic bacteriuria: antibiotic vs. no treatment for asymptomatic bacteriuria in pregnancy. Cochrane Database of Systematic Reviews. 2002;(3):1–5.
352.
Villar J, Lydon-Rochelle MT, Gulmezoglu AM. Duration of treatment for asymptomatic bacteriuria during pregnancy. Cochrane Database of Systematic Reviews. 2001;(2) [PubMed: 10796207]
353.
Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. Morbidity and Mortality Weekly Report. 2002;51:1–80. [PubMed: 12184549]
354.
Joesoef M, Schmid G. Bacterial vaginosis. Clinical Evidence. 2002;7:1400–8. [PubMed: 12230755]
355.
Goldenberg RL, Klebanoff MA, Nugent R, Krohn MA, Hilliers S, Andrews WW. Bacterial colonization of the vagina during pregnancy in four ethnic groups. Vaginal Infections and Prematurity Study Group. American Journal of Obstetrics and Gynecology. 1996;174:1618–21. [PubMed: 9065140]
356.
Hay PE, Morgan DJ, Ison CA, Bhide SA, Romney M, McKenzie P, et al. A longitudinal study of bacterial vaginosis during pregnancy. British Journal of Obstetrics and Gynaecology. 1994;101:1048–53. [PubMed: 7826957]
357.
Flynn CA, Helwig AL, Meurer LN. Bacterial vaginosis in pregnancy and the risk of prematurity: a meta-analysis. Journal of Family Practice. 1999;48:885–92. [PubMed: 10907626]
358.
Gratacos E, Figueras F, Barranco M, Vila J, Cararach V, Alonso PL, et al. Spontaneous recovery of bacterial vaginosis during pregnancy is not associated with an improved perinatal outcome. Acta Obstetricia et Gynecologica Scandinavica. 1998;77:37–40. [PubMed: 9492715]
359.
Amsel R, Totten PA, Spiegel CA. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiological associations. American Journal of Medicine. 1983;74:14–22. [PubMed: 6600371]
360.
Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardised methods of Gram stain interpretation. Journal of Clinical Microbiology. 1991;29:297–301. [PMC free article: PMC269757] [PubMed: 1706728]
361.
Thiagarajan M. Evaluation of the use of yogurt in treating bacterial vaginosis in pregnancy. Journal of Clinical Epidemiology. 1998;51:22S.
362.
McDonald H, Brocklehurst P, Parsons J, Vigneswaran R. Interventions for treating bacterial vaginosis in pregnancy. Cochrane Database of Systematic Reviews. 2003;(2):1–30. [PubMed: 12804393]
363.
Ugwumadu A, Manyonda I, Reid F, Hay P. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet. 2003;361:983–8. [PubMed: 12660054]
364.
Stary A. European guideline for the management of chlamydial infection. International Journal of STD and AIDS. 2001;12:30–3. [PubMed: 11589794]
365.
Preece PM, Ades A, Thompson RG, Brooks JH. Chlamydia trachomatis infection in late pregnancy: A prospective study. Paediatric and Perinatal Epidemiology. 1989;3:268–77. [PubMed: 2788879]
366.
Goh BT, Morgan-Capner P, Lim KS. Chlamydial screening of pregnant women in a sexually transmitted diseases clinic. British Journal of Venereal Diseases. 1982;58:327–9. [PMC free article: PMC1046086] [PubMed: 6897007]
367.
Association of chlamydia trachomatis and mycoplasma hominis with intrauterine growth restriction and preterm delivery. The John Hopkins Study of Cervicitis and Adverse Pregnancy Outcome. American Journal of Epidemiology. 1989;129:1247–51. [PubMed: 2729260]
368.
Ryan GM Jr, Abdella TN, McNeeley SG, Baselski VS, Drummond DE. Chlamydia trachomatis infection in pregnancy and effect of treatment on outcome. [see comments.] American Journal of Obstetrics and Gynecology. 1990;162:34–9. [PubMed: 2301514]
369.
Brocklehurst P, Rooney G. Interventions for treating genital chlamydia trachomatis infection in pregnancy. Cochrane Database of Systematic Reviews. 2002;(3) [PubMed: 10796106]
370.
Preece PM, Anderson JM, Thompson RG. Chlamydia trachomatis infection in infants: A prospective study. Archives of Disease in Childhood. 1989;64:525–9. [PMC free article: PMC1791958] [PubMed: 2751326]
371.
Schachter J, Grossman M, Sweet RL, Holt J, Jordan C, Bishop E. Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA. 1986;255:3374–7. [PubMed: 3712696]
372.
FitzGerald MR, Welch J, Robinson AJ, Ahmed-Jushuf IH. Clinical guidelines and standards for the management of uncomplicated genital chlamydial infection. International Journal of STD and AIDS. 1998;9:253–62. [PubMed: 9639202]
373.
Scottish Intercollegiate Guidelines Network. Management of genital Chlamydia trachomatis, Infection. SIGN Publication No. 42. Edinburgh: Scottish Intercollegiate Guideline Network; 2000.
374.
Ryan M, Miller E, Waight P. Cytomegalovirus infection in England and Wales: 1992 and 1993. Communicable Diseases Report. 1995;5:R74–6. [PubMed: 7749457]
375.
Preece PM, Tookey P, Ades A, Peckham CS. Congenital cytomegalovirus infection: predisposing maternal factors. Journal of Epidemiology and Community Health. 1986;40:205–9. [PMC free article: PMC1052523] [PubMed: 3021888]
376.
Peckham CS, Coleman JC, Hurley R, Chin KS, Henderson K, Preece PM. Cytomegalovirus infection in pregnancy: preliminary findings from a prospective study. Lancet. 1983:1352–5. [PubMed: 6134135]
377.
Bolyard EA, Tablan OC, Williams WW, Pearson ML, Shapiro CN, Deitchmann SD. Guideline for infection control in health care personnel. Centers for Disease Control and Prevention. Infection Control and Hospital Epidemiology. 1998;19:407–63. Erratum 1998;19:493. [PubMed: 9669622]
378.
Stagno S, Whitley RJ. Herpesvirus infections of pregnancy. Part 1: Cytomegalovirus and Epstein-Barr virus infections. New England Journal of Medicine. 1985;313:1270–4. [PubMed: 2997607]
379.
Boxall E, Skidmore S, Evans C, Nightingale S. The prevalence of hepatitis B and C in an antenatal population of various ethnic origins. Epidemiology and Infection. 1994;113:523–8. [PMC free article: PMC2271311] [PubMed: 7527780]
380.
Brook MG, Lever AM, Kelly D, Rutter D, Trompeter RS, Griffiths P, et al. Antenatal screening for hepatitis B is medically and economically effective in the prevention of vertical transmission: three years experience in a London hospital. Quarterly Journal of Medicine. 1989;71:313–7. [PubMed: 2594961]
381.
Chrystie I, Sumner D, Palmer S, Kenney A, Banatvala J. Screening of pregnant women for evidence of current hepatitis B infection: selective or universal? Health Trends. 1992;24:13–5. [PubMed: 10122485]
382.
Derso A, Boxall EH, Tarlow MJ, Flewett TH. Transmission of HBsAg from mother to infant in four ethnic groups. British Medical Journal. 1978;15(6118):949–952. [PMC free article: PMC1603798] [PubMed: 638544]
383.
Beasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. American Journal of Epidemiology. 1977;105:94–8. [PubMed: 835566]
384.
Beasley RP, Hwang L-Y. Epidemiology of hepatocellular carcinoma, Viral hepatitis and liver disease. Vyas GN, Dienstag JL, Hoofnagle JH, editors. Orlando, FL: Grune and Stratton; 1984. pp. 209–24.
385.
Ramsay M, Gay N, Balogun K, Collins M. Control of hepatitis B in the United Kingdom. Vaccine. 1998;16(Suppl):S52–5. [PubMed: 9915036]
386.
Sehgal A, Sehgal R, Gupta I, Bhakoo ON, Ganguly NK. Use of hepatitis B vaccine alone or in combination with hepatitis B immunoglobulin for immunoprophylaxis of perinatal hepatitis B infection. Journal of Tropical Pediatrics. 1992;38:247–51. [PubMed: 1433451]
387.
Wong VC, Ip HM, Reesink HW, Lelie PN, Reerink-Brongers EE, Yeung CY, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. Lancet. 1984;1:921–6. [PubMed: 6143868]
388.
Zhu Q. A preliminary study on interruption of HBV transmission in uterus. Chinese Medical Journal. 1997;110:145–7. [PubMed: 9594288]
389.
Lo K, Tsai Y, Lee S, Yeh C, Wang J, Chiang BN, et al. Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan. Hepato-gastroenterology. 1985;32:65–8. [PubMed: 3159639]
390.
Beasley RP, Hwang LY, Lee GC, Lan CC, Roan CH, Huang FY, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983;2:1099–102. [PubMed: 6138642]
391.
Nair PV, Weissman JY, Tong MJ, Thursby MW, Paul RH, Henneman CE. Efficacy of hepatitis B immune globulin in prevention of perinatal transmission of the hepatitis B virus. Gastroenterology. 1984;87:293–8. [PubMed: 6376265]
392.
Xu Z-Y, Liu C-B, Francis DP. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial. Pediatrics. 1985;76:713–18. [PubMed: 3903646]
393.
Balmer S, Bowens A, Bruce E, Farrar H, Jenkins C, Williams R. Quality management for screening: report to the National Screening Committee. Leeds: Nuffield Institute for Health; 2000.
394.
Summers PR, Biswas MK, Pastorek JG, Pernoll ML, Smith LG, Bean BE. The pregnant hepatitis B carrier: evidence favoring comprehensive antepartum screening. Obstetrics and Gynecology. 1987;69:701–4. [PubMed: 3574797]
395.
Chaita TM, Graham SM, Maxwell SM, Sirivasin W, Sabchareon A, Beeching NJ. Salivary sampling for hepatitis B surface antigen carriage: a sensitive technique suitable for epidemiological studies. Annals of Tropical Paediatrics. 1995;15:135–9. [PubMed: 7677414]
396.
Pembrey L, Newell ML, Tovo PA. Hepatitis C virus infection in pregnant women and their children. Italian Journal of Gynaecology and Obstetrics. 2000;12:21–8.
397.
Whittle M, Peckham C, Anionwu E, et al. Antenatal screening for hepatitis C. Working party report on screening for hepatitis C in the UK. Jan, 2002. [Accessed 4 September 2003]. [ www​.nelh.nhs.uk/screening​/antenatal_pps/Hep_C_NSC.pdf]
398.
Ades AE, Parker S, Walker J, Cubitt WD, Jones R. HCV prevalence in pregnant women in the UK. Epidemiology and Infection. 2000;125:399–405. [PMC free article: PMC2869613] [PubMed: 11117964]
399.
Okamoto M, Nagata I, Murakami J, Kaji S, Iitsuka T, Hoshika T, et al. Prospective reevaluation of risk factors in mother-to-child transmission of hepatitis C virus: high virus load, vaginal delivery, and negative anti-NS4 antibody. Journal of Infectious Diseases. 2000;182:1511–4. [PubMed: 11023474]
400.
Tajiri H, Miyoshi Y, Funada S, Etani Y, Abe J, Onodera T, et al. Prospective study of mother-to-infant transmission of hepatitis C virus. Pediatric Infectious Disease Journal. 2001;20:10–4. [PubMed: 11176560]
401.
Paccagnini S, Principi N, Massironi E, Tanzi E, Romano L, Muggiasca ML, et al. Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. Pediatric Infectious Disease Journal. 1995;14:195–9. [PubMed: 7761184]
402.
Tovo PA, Pembrey L, Newell M-L. Persistence rate and progression of vertically acquired hepatitis C infection. Journal of Infectious Diseases. 2001;181:419–24. [PubMed: 10669321]
403.
Ketzinel-Gilad M, Colodner SL, Hadary R, Granot E, Shouval D, Galun E. Transient transmission of hepatitis C virus from mothers to newborns. European Journal of Clinical Microbiology and Infectious Diseases. 2000;19:267–74. [PubMed: 10834815]
404.
Lin HH, Kao J-H. Effectiveness of second- and third-generation immunoassays for the detection of hepatitis C virus infection in pregnant women. Journal of Obstetrics and Gynaecology Research. 2000;26:265–70. [PubMed: 11049236]
405.
Vrielink H, Reesink HW, van den Burg PJ. Performance of three generations of anti-hepatitis C virus enzyme-linked immunosorbent assays in donors and patients. Vox Sanguinis. 1997;72:67–70. [PubMed: 9280331]
406.
Zaaijer HL, Vrielink H, Van Exel-Oehlers PJ, Cuypers HT, Lelie PN. Confirmation of hepatitis C infection: a comparison of five immunoblot assays. Transfusion. 1993;33:634–8. [PubMed: 7519796]
407.
Unlinked Anonymous Surveys Steering Group. Annual report of the Unlinked Anonymous Prevalence Monitoring Programme. London: Department of Health; 2002. [Accessed 21 August 2003]. Prevalence of HIV and hepatitis infections in the United Kingdom 2001. [ www​.doh.gov.uk/hivhepatitis​/hivhepatitis2001.pdf]
408.
Unlinked Anonymous Surveys Steering Group. Prevalence of HIV and hepatitis infections in the United Kingdom 2000, Annual report of the Unlinked Anonymous Prevalence Monitoring Programme. London: Department of Health; 2001. pp. 5pp. 7pp. 24–30.
409.
Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O’Sullivan MJ, et al. Reduction of maternal–infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. New England Journal of Medicine. 1994;331:1173–80. [PubMed: 7935654]
410.
Mandelbrot L, Le Chenadec J, Berrebi A, Bongain A, Benifla J-L, Delfraissy JF, et al. Perinatal HIV-1 transmission. Interaction between zidovudine prophylaxis and mode of delivery in the French perinatal cohort. JAMA. 1998;280:55–60. [PubMed: 9660364]
411.
Duong T, Ades AE, Gibb DM, Tookey PA, Masters J. Vertical transmission rates for HIV in the British Isles: estimates based on surveillance data. British Medical Journal. 1999;319:1227–9. [PMC free article: PMC28270] [PubMed: 10550082]
412.
AIDS and HIV infection in the United Kingdom: monthly report. CDR Weekly. 2001. [Accessed 4 September 2003]. pp. 10–15. [ www​.phls.org.uk/publications​/cdr/PDFfiles/2001/cdr1701.pdf]
413.
Samson L, King S. Evidence-based guidelines for universal counselling and offering of HIV testing in pregnancy in Canada. Canadian Medical Association Journal. 1998;158:1449–57. [erratum appears in CMAJ 1999;159(1):22. [PMC free article: PMC1229371] [PubMed: 9629106]
414.
Van Doornum GJJ, Buimer M, Gobbers E, Bindels PJ, Coutinho RA. Evaluation of an expanded two-ELISA approach for confirmation of reactive serum samples in an HIV-screening programme for pregnant women. Journal of Medical Virology. 1998;54:285–90. [PubMed: 9557294]
415.
Public Health Laboratory Service AIDS Diagnosis Working Group. Towards error free HIV diagnosis: notes on laboratory practice. PHLS Microbiology Digest. 1992;9:61–4.
416.
Brocklehurst P, Volmink J. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database of Systematic Reviews. 2002;(3) [PubMed: 11869666]
417.
European Mode of Delivery Collaboration. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. The European Mode of Delivery Collaboration. Lancet. 1999;353:1035–9. [published erratum appears in Lancet 1999;353:1714] [PubMed: 10199349]
418.
Ricci E, Parazzini F. Caesarean section and antiretroviral treatment. Lancet. 2000;355:496. [PubMed: 10841153]
419.
Cunningham CK, Chaix ML, Rekacewicz C, Britto P, Rouzioux C, Gelber RD, et al. Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group protocol 316. Journal of Infectious Diseases. 2002;186:181–8. [PubMed: 12134253]
420.
Palumbo P, Holland B, Dobbs T, Pau CP, Luo CC, Abrams EJ, et al. Antiretroviral resistance mutations among pregnant human immunodeficiency virus type 1-infected women and their newborns in the United States: vertical transmission and clades. Journal of Infectious Diseases. 2001;184:1120–6. [PubMed: 11598834]
421.
Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. Morbidity and Mortality Weekly Report. 2001;50:1–23. [PubMed: 11475328]
422.
Tookey P. Antenatal screening for rubella. Personal communication. 2002.
423.
Miller E, Waight P, Gay N, Ramsay M, Vurdien J, Morgan-Capner P, et al. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Communicable Diseases Report. 1997;7:R26–32. [PubMed: 9046126]
424.
Tookey PA, Corina-Borja M, Peckham CS. Rubella susceptibility among pregnant women in North London, 1996–1999. Journal of Public Health Medicine. 2002;24:211–6. [PubMed: 12831092]
425.
Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet. 1982;2:781–4. [PubMed: 6126663]
426.
Grangeot-Keros L, Enders G. Evaluation of a new enzyme immunoassay based on recombinant Rubella virus-like particles for detection of immunoglobulin M antibodies to Rubella virus. Journal of Clinical Microbiology. 1997;35:398–401. [PMC free article: PMC229588] [PubMed: 9003604]
427.
Morgan-Capner P, Crowcroft NS. Guidelines on the management of, and exposure to, rash illness in pregnancy (including consideration of relevant antibody screening programmes in pregnancy). On behalf of the PHLS joint working party of the advisory committees of virology and vaccines and immunisation. Communicable Disease and Public Health/PHLS. 2002;5(1):59–71. [PubMed: 12070980]
428.
Grillner L, Forsgren M, Barr B. Outcome of rubella during pregnancy with special reference to the 17th–24th weeks of gestation. Scandinavian Journal of Infectious Diseases. 1983;15:321–5. [PubMed: 6658380]
429.
Morgan-Capner P, Hodgson J, Hambling MH. Detection of rubella-specific IgM in subclinical rubella reinfection in pregnancy. Lancet. 1985;1:244–6. [PubMed: 2857319]
430.
Revised ACIP recommendation for avoiding pregnancy after receiving a rubella-containing vaccine. MMWR–Morbidity and Mortality Weekly Report. 2001;50:1117. [PubMed: 11794623]
431.
Health Protection Agency. Incidence of Group B streptococcal disease in infants aged less than 90 days old. CDR Weekly. 2002. [Accessed 21 August 2003]. p. 3. [ 193​.129.245.226/publications​/cdr/archive02/News/news1602​.html gpB]
432.
Merenstein GB, Todd WA, Brown G. Group B beta-hemolytic streptococcus: Randomized controlled treatment study at term. Obstetrics and Gynecology. 1980;55:315–8. [PubMed: 6987582]
433.
Regan JA, Klebanoff MA, Nugent RP. The epidemiology of Group B streptococcal colonization in pregnancy. Obstetrics and Gynecology. 1991;77:604–10. [PubMed: 2002986]
434.
Hastings MJ, Easmon CS, Neill J, Bloxham B, Rivers RP. Group B streptococcal colonisation and the outcome of pregnancy. Journal of Infection. 1986;12:23–9. [PubMed: 3514769]
435.
Oddie S, Embleton ND. Risk factors for early onset neonatal group B streptococcal sepsis: case–control study. British Medical Journal. 2002;325:308. [PMC free article: PMC117770] [PubMed: 12169506]
436.
Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease. Revised Guidelines from CDC. Morbidity and Mortality Weekly Report. 2002. [Accessed 21 August 2003]. pp. 1–25. [ www​.cdc.gov/mmwr/preview​/mmwrhtml/rr5111a1.htm] [PubMed: 12211284]
437.
Fey R, Stuart J, George R. Neonatal group B streptococcal disease in England and Wales 1981–1997. Archives of Disease in Childhood. 1999;80:A70.
438.
Bignardi GE. Surveillance of neonatal group B streptococcal infection in Sunderland. Communicable Disease and Public Health/PHLS. 1999;2(1):64–5. [PubMed: 10462900]
439.
Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstetrics and Gynecology. 1996;88:811–5. [PubMed: 8885919]
440.
Boyer KM, Gadzala CA, Kelly PD, Burd LI, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. Journal of Infectious Diseases. 1983;148:802–9. [PubMed: 6355317]
441.
Molnar P, Biringer A, McGeer A, McIsaac W. Can pregnant women obtain their own specimens for group B streptococcus? A comparison of maternal versus physician screening. The Mount Sinai GBS Screening Group. Family Practice. 1997;14:403–6. [PubMed: 9472376]
442.
Spieker MR, White DG, Quist BK. Self-collection of group B Streptococcus cultures in pregnant women. Military Medicine. 1999;164:471–4. [PubMed: 10414060]
443.
Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. New England Journal of Medicine. 2002;347:233–9. [PubMed: 12140298]
444.
Smaill F. Intrapartum antibiotics for group B streptococcal colonisation. Cochrane Database of Systematic Reviews. 1999;(3):1–5. [PubMed: 20091501]
445.
Benitz WE, Gould JB, Druzin ML. Antimicrobial prevention of early-onset group B streptococcal sepsis: estimates of risk reduction based on a critical literature review. Pediatrics. 1999;103:e78. [PubMed: 10353975]
446.
Gibbs RS, McNabb F. Randomized clinical trial of intrapartum clindamycin cream for reduction of group B streptococcal maternal and neonatal colonization. Infectious Disease in Obstetrics and Gynecology. 1996;41:25–7. [PMC free article: PMC2364464] [PubMed: 18476060]
447.
Schrag SJ, Zywicki S, Farley MM, Reingold AL. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. New England Journal of Medicine. 2000;342:15–20. [PubMed: 10620644]
448.
Jeffery HE, Moses LM. Eight-year outcome of universal screening and intrapartum antibiotics for maternal group B streptococcal carriers. Pediatrics. 1998;101:E2. [PubMed: 9417166]
449.
Egglestone SI, Turner AJL. Serological diagnosis of syphilis. Communicable Disease and Public Health/PHLS. 2000;3:158–62. [PubMed: 11014025]
450.
Doherty L, Fenton KA, Jones J, Paine TC, Higgins SP, Williams D, et al. Syphilis: old problem, new strategy. British Medical Journal. 2002;325:153–6. [PMC free article: PMC1123676] [PubMed: 12130615]
451.
Division of STD/HIV Prevention. Sexually Transmitted Disease Surveillance 1993. Atlanta, GA: Centers for Disease Control and Prevention; 1994.
452.
Flowers J, Camilleri-Ferrante Antenatal screening for syphilis in East Anglia: a cost-benefit analysis. Cambridge: Institute of Public Health; 1996.
453.
STD Section, HIV and STD Division, PHLS Communicable Disease Surveillance Centre, with the PHLS Syphilis Working Group. Report to the National Screening Committee, Antenatal Syphilis Screening in the UK: A Systematic Review and National Options Appraisal with Recommendations. London: PHLS; 1998.
454.
Public Health Laboratory Service, DHSS & PS, Scottish ISD D 5 Collaborative Group. Sexually transmitted infections in the UK: new episodes seen at Genitourinary Medicine Clinics, 1995–2000. London: PHLS; 2001.
455.
Ingraham NR Jr. The value of penicillin alone in the prevention and treatment of congenital syphilis. Acta Dermato-Venereologica. 1951;31:60–88. [PubMed: 14829195]
456.
Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases, Clinical Effectiveness Group. UK national guidelines on the management of early syphilis. London: Medical Society for the Study of Venereal Diseases; 2002. pp. 1–18.
457.
Goh BT, van Voorst Vader PC. European guideline for the management of syphilis. International Journal of STD and AIDS. 2001;12:14–26. [PubMed: 11589792]
458.
Fiumara NJ, Fleming WL, Downing JG, Good FL. The incidence of prenatal syphilis at the Boston City Hospital. New England Journal of Medicine. 1952;247:48–52. [PubMed: 14941281]
459.
Rotchford K, Lombard C, Zuma K, Wilkinson D. Impact on perinatal mortality of missed opportunities to treat maternal syphilis in rural South Africa: baseline results from a clinic randomized controlled trial. Tropical Medicine and International Health. 2000;5:800–4. [PubMed: 11123828]
460.
Young H, Moyes A, McMillan A, Patterson J. Enzyme immunoassay for anti-treponemal IgG: Screening of confirmatory test? Journal of Clinical Pathology. 1992;45:37–41. [PMC free article: PMC495810] [PubMed: 1740512]
461.
Young H, Moyes A, McMillan A, Robertson DHH. Screening for treponemal infection by a new enzyme immunoassay. Genitourinary Medicine. 1989;65:72–8. [PMC free article: PMC1194290] [PubMed: 2666302]
462.
Walker GJA. Antibiotics for syphilis diagnosed during pregnancy [protocol] Cochrane Database of Systematic Reviews. 2001;(2) [PubMed: 11686978]
463.
Alexander JM, Sheffield JS, Sanchez PJ, Mayfield J, Wendel GD Jr. Efficacy of treatment for syphilis in pregnancy. Obstetrics and Gynecology. 1999;93:5–8. [PubMed: 9916946]
464.
Watson-Jones D, Gumodoka B, Weiss H, Changalucha J, Todd J, Mugeye K, et al. Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screening and single-dose benzathine penicillin treatment for the prevention of adverse pregnancy outcomes. Journal of Infectious Diseases. 2002;186:948–57. [PubMed: 12232835]
465.
Hashisaki P, Wertzberger GG, Conrad GL, Nicholes CR. Erythromycin failure in the treatment of syphilis in a pregnant woman. Sexually Transmitted Diseases. 1983;10:36–8. [PubMed: 6601848]
466.
Eskild A, Oxman A, Magnus P, Bjorndal A, Bakketeig LS. Screening for toxoplasmosis in pregnancy: what is the evidence of reducing a health problem? Journal of Medical Screening. 1996;3:188–94. [PubMed: 9041483]
467.
Ades AE, Parker S, Gilbert R, Tookey PA, Berry T, Hjelm M, et al. Maternal prevalence of toxoplasma antibody based on anonymous neonatal serosurvey: a geographical analysis. Epidemiology and Infection. 1993;110:127–33. [PMC free article: PMC2271970] [PubMed: 8432316]
468.
Allain JP, Palmer CR, Pearson G. Epidemiological study of latent and recent infection by toxoplasma gondii in pregnant women from a regional population in the UK. Journal of Infection. 1998;36:189–96. [PubMed: 9570653]
469.
Lebech M, Andersen O, Christensen NC, Hertel J, Nielsen HE, Peitersen B, et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet. 1999;353:1834–7. [PubMed: 10359408]
470.
Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, et al. Sources of toxoplasma infection in pregnant women: European multicentre case–control study. European Research Network on Congenital Toxoplasmosis. British Medical Journal. 2000;321:142–7. [PMC free article: PMC27431] [PubMed: 10894691]
471.
Pratlong F, Boulot P, Villena I, Issert E, Tamby I, Cazenave J, et al. Antenatal diagnosis of congenital toxoplasmosis: evaluation of the biological parameters in a cohort of 286 patients. British Journal of Obstetrics and Gynaecology. 1996;103:552–7. [PubMed: 8645648]
472.
Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet. 1999;353:1829–33. [PubMed: 10359407]
473.
Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, Pinon JM, et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children’s sequelae at age 1 year. American Journal of Obstetrics and Gynecology. 1999;180:410–5. [PubMed: 9988811]
474.
Cubitt WD, Ades AE, Peckham CS. Evaluation of five commercial assays for screening antenatal sera for antibodies to Toxoplasma gondii. Journal of Clinical Pathology. 1992;45:435–8. [PMC free article: PMC495309] [PubMed: 1597524]
475.
Gilbert RE, Peckham CS. Congenital toxoplasmosis in the United Kingdom: to screen or not to screen? Journal of Medical Screening. 2002;9:135–41. [PubMed: 12370327]
476.
Peyron F, Wallon M, Liou C, Garner P. Treatments for toxoplasmosis in pregnancy. Cochrane Database of Systematic Reviews. 2002;(3) [PubMed: 10796268]
477.
Wallon M, Liou C, Garner P, Peyron F. Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. British Medical Journal. 1999;318:1511–14. [PMC free article: PMC27891] [PubMed: 10356003]
478.
Garland SM, O’Reilly MA. The risks and benefits of antimicrobial therapy in pregnancy. Drug Safety. 1995;13:188–205. [PubMed: 7495503]
479.
Bader TJ, Macones GA, Asch DA. Prenatal screening for toxoplasmosis. Obstetrics and Gynecology. 1997;90:457–64. [PubMed: 9277662]
480.
Scottish Intercollegiate Guidelines Network. SIGN Publication No. 55. Edinburgh: SIGN; 2001. [Accessed 21 August 2003]. Management of diabetes: a national clinical guideline. [ www​.sign.ac.uk/guidelines​/fulltext/55/index.html]
481.
World Health Organization, Department of Noncommunicable Disease Surveillance. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation, Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999.
482.
Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine. 1998;15:539–53. [PubMed: 9686693]
483.
Scott DA, Loveman E, McIntyre L, Waugh N. Screening for gestational diabetes: a systematic review and economic evaluation. Health Technology Assessment. 2002;6:1–172. [PubMed: 12433317]
484.
World Health Organization. Prevention of diabetes mellitus: report of a WHO study group, WHO Technical Report Series No. 844. Geneva: WHO; 1994. [PubMed: 7941615]
485.
Mestman JH, Anderson GV, Guadalupe V. Follow-up study of 360 subjects with abnormal carbohydrate metabolism during pregnancy. Obstetrics and Gynecology. 1972;39:421–5. [PubMed: 5019316]
486.
Jensen DM, Sorensen B, Feilberg-Jorgensen N, Westergaard JG, Beck-Neilsen H. Maternal and perinatal outcomes in 143 Danish women with gestational diabetes mellitus and 143 controls with a similar risk profile. Diabetic Medicine. 2000;17:281–6. [PubMed: 10821294]
487.
O’Sullivan JB, Charles D, Mahan CM, Dandrow RV. Gestational diabetes and perinatal mortality rate. American Journal of Obstetrics and Gynecology. 1973;116:901–4. [PubMed: 4718217]
488.
Essel JK, Opai-Tetteh ET. Macrosomia: maternal and fetal risk factors. South African Medical Journal. 1995;85(1):43–6. [PubMed: 7784919]
489.
Vogel N, Burnand B, Vial Y, Ruiz J, Paccaud F, Hohlfeld P. Screening for gestational diabetes: variation in guidelines European Journal Obstetrics, Gynecology and Reproductive Biology20009129–36. [PubMed: 10817875]
490.
Marquette GP, Klein VR, Niebyl JR. Efficacy of screening for gestational diabetes. American Journal of Perinatology. 1985;2:7–9. [PubMed: 3921038]
491.
O’Sullivan JB, Mahan CM, Charles D, Dandrow RV. Screening criteria for high-risk gestational diabetic patients. American Journal of Obstetrics and Gynecology. 1973;116:895–900. [PubMed: 4718216]
492.
Wen SW, Liu S, Kramer MS, Joseph KS, Levitt C, Marcoux S, et al. Impact of prenatal glucose screening on the diagnosis of gestational diabetes and on pregnancy outcomes. American Journal of Epidemiology. 2000;152:1009–14. [PubMed: 11117609]
493.
Watson WJ. Screening for glycosuria during pregnancy. Southern Medical Journal. 1990;83:156–8. [PubMed: 2305295]
494.
Gribble RK, Meier PR, Berg RL. The value of urine screening for glucose at each prenatal visit. Obstetrics and Gynecology. 1995;86:405–10. [PubMed: 7651652]
495.
Hooper DE. Detecting GD and preeclampsia. Effectiveness of routine urine screening for glucose and protein. Journal of Reproductive Medicine. 1996;41:885–8. [PubMed: 8979200]
496.
McElduff A, Goldring J, Gordon P, Wyndham L. A direct comparison of the measurement of a random plasma glucose and a post50 g glucose load glucose, in the detection of gestational diabetes. Australian and New Zealand Journal of Obstetrics and Gynaecology. 1994;34:28–30. [PubMed: 8053872]
497.
Jowett NI, Samanta AK, Burden AC. Screening for diabetes in pregnancy: is a random blood glucose enough? Diabetic Medicine. 1987;4:160–3. [PubMed: 2952435]
498.
Reichelt AJ, Spichler ER, Branchtein L, Nucci LB, Franco LJ, Schmidt MI. Fasting plasma glucose is a useful test for the detection of gestational diabetes. Brazilian Study of Gestational Diabetes (EBDG) Working Group. Diabetes Care. 1998;21:1246–9. [PubMed: 9702428]
499.
Perucchini D, Fischer U, Spinas GA, Huch R, Huch A, Lehmann R. Using fasting plasma glucose concentrations to screen for gestational diabetes mellitus: prospective population based study. British Medical Journal. 1999;319:812–5. [PMC free article: PMC314206] [PubMed: 10496823]
500.
Lewis GF, McNally C, Blackman JD, Polonsky KS, Barron WM. Prior feeding alters the response to the 50 g glucose challenge test in pregnancy. The Staub-Traugott Effect revisited. Diabetes Care. 1993;16:1551–6. [PubMed: 8299450]
501.
Watson WJ. Serial changes in the 50-g oral glucose test in pregnancy: implications for screening. Obstetrics and Gynecology. 1989;74:40–3. [PubMed: 2733939]
502.
Jovanovic L, Peterson CM. Screening for gestational diabetes. Optimum timing and criteria for retesting. Diabetes. 1985;34:21–3. [PubMed: 3996766]
503.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2000;26(Supplement 1):S5–S20. [PubMed: 12502614]
504.
Walkinshaw SA. Dietary regulation for ‘gestational diabetes’ Cochrane Database of Systematic Reviews. 2000;(2) [PubMed: 10796112]
505.
Persson B, Stangenberg M, Hansson U, Nordlander E. Gestational diabetes mellitus (GDM). Comparative evaluation of two treatment regimens, diet versus insulin and diet. Diabetes. 1985;34:101–4. [PubMed: 3888734]
506.
Naylor CD, Sermer M, Chen E, Sykora K. Cesarean delivery in relation to birth weight and gestational glucose tolerance. Pathophysiology or practice style? JAMA. 1996;275:1165–70. [PubMed: 8609683]
507.
Avery MD, Leon AS, Kopher RA. Effects of a partially home-based exercise program for women with gestational diabetes. Obstetrics and Gynecology. 1997;89:10–5. [PubMed: 8990428]
508.
Goldberg JD, Franklin B, Lasser D, Jornsay DL, Hausknecht RU, Ginsberg-Fellner F, et al. Gestational diabetes: impact of home glucose monitoring on neonatal birth weight. American Journal of Obstetrics and Gynecology. 1986;154:546–50. [PubMed: 3513584]
509.
Roberts JM, Redman CW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet. 1993;341:1447–51. [PubMed: 8099148]
510.
Douglas KA, Redman CW. Eclampsia in the United Kingdom. British Medical Journal. 1994;309:1395–400. [PMC free article: PMC2541348] [PubMed: 7819845]
511a.
National High Blood Pressure Education Programme. Working Group Report on high blood pressure in pregnancy, NIH Publication 00–3029. Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute; 2000.
511b.
National High Blood Pressure Education Program Working Group. Report on high blood pressure in pregnancy. American Journal of Obstetrics and Gynecology. 1990;163:1691–712. [PubMed: 2104525]
512.
Duckitt K. Risk factors for pre-eclampsia that can be assessed at the antenatal booking visit: a systematic review. Presented at the International Society for the Study of Hypertension in Pregnancy Conference; 24–25 July 2003; Glasgow. 2003.
513.
Friedman EA. Blood pressure, edema and proteinuria in pregnancy. Oxford: Elsevier Scientific; 1976.
514.
Redman CW. Hypertension in pregnancy. 1995. pp. 182–225.
515.
Barton JR, O’Brien JM, Bergauer NK, Jacques DL, Sibai BM. Mild gestational hypertension remote from term: progression and outcome. American Journal of Obstetrics and Gynaecology. 2001;184:979–83. [PubMed: 11303208]
516a.
Page EW, Christianson R. The impact of mean arterial pressure in the middle trimester upon the outcome of pregnancy. American Journal of Obstetrics and Gynecology. 1976;125:740–6. [PubMed: 937399]
516b.
Page EW, Christianson R. Influence of blood pressure changes with and without proteinuria upon outcome of pregnancy. American Journal of Obstetrics and Gynecology. 1976;126:821–33. [PubMed: 998675]
517.
Greer IA. Hypertension, High risk pregnancy. Dunlop W, Calder AA, editors. Oxford: Butterworth Heinemann; 1992. pp. 30–93.
518.
Redman CW, Jefferies M. Revised definition of pre-eclampsia. Lancet. 1988;1:809–12. [PubMed: 2895326]
519.
North RA, Taylor RS, Schellenberg JC. Evaluation of a definition of pre-eclampsia. British Journal of Obstetrics and Gynaecology. 1999;106:767–73. [PubMed: 10453825]
520.
Levine RJ. Should the definition of preeclampsia include a rise in diastolic blood pressure > 15 mmHg to a level < 90 mmHg in association with proteinuria? American Journal of Obstetrics and Gynecology. 2000;183:787–92. [PubMed: 11035314]
521.
Perry IJ, Wilkinson LS, Shinton RA, Beevers DG. Conflicting views on the measurement of blood pressure in pregnancy. British Journal of Obstetrics and Gynaecology. 1991;98:241–3. [PubMed: 2021560]
522.
Frohlich ED, Grim C, Labarthe DR, Maxwell MH, Perloff D, Weidman WH. Recommendations for human blood pressure determination by sphygmomanometers: Report of a special task force appointed by the Steering Committee, American Heart Association. Hypertension. 1988;11:210A–22A.
523.
Petrie JC, O’Brien ET, Littler WA, de Swiet M. Recommendations on blood pressure measurement. British Medical Journal. 1986;293:611–5. [PMC free article: PMC1341395] [PubMed: 3092951]
524.
Shennan AH, Halligan AWF. Measuring blood pressure in normal and hypertensive pregnancy. Baillieres Clinical Obstetrics and Gynaecology. 1999;13(1):1–26. [PubMed: 10746090]
525.
Cuckson AC, Golara M, Reinders A, Shennan AH. Accuracy of automated devices in pregnancy and pre-eclampsia: a metaanalysis. Journal of Obstetrics and Gynaecology. 2002;22:S43.
526.
Mattoo TK. Arm cuff in the measurement of blood pressure. American Journal of Hypertension. 2002;15:675–85. [PubMed: 11866235]
527.
Brown MA, Buddle ML, Farrell T, Davis G, Jones M. Randomised trial of management of hypertensive pregnancies by Korotkoff phase IV or phase V. Lancet. 1998;352:777–81. [PubMed: 9737283]
528.
Shennan A, Gupta M, Halligan A, Taylor DJ, de Swiet M. Lack of reproducibility in pregnancy of Korotkoff phase IV as measured by mercury sphygmomanometry. Lancet. 1996;347:139–42. [PubMed: 8544546]
529.
MacGillivray I. Pre-eclampsia, The hypertensive disease of pregnancy. London: WB Saunders; 1983.
530.
Stamilio DM, Sehdev HM, Morgan MA, Propert K, Macones GA. Can antenatal clinical and biochemical markers predict the development of severe preeclampsia? American Journal of Obstetrics and Gynecology. 2000;182:589–94. [PubMed: 10739512]
531.
Skjaerven R, Wilcox AJ, Lie RT. The interval between pregnancies and the risk of preeclampsia. New England Journal of Medicine. 2002;346:33–8. [PubMed: 11778000]
532.
Taylor DJ. The epidemiology of hypertension during pregnancy, Hypertension in pregnancy. Rubin PC, editor. Amsterdam: Elsevier Science; 1988. pp. 223–40.
533.
Salonen-Ros H, Lichtenstein P, Lipworth W. Genetic effects on the liability of developing pre-eclampsia and gestational hypertension. American Journal of Medical Genetics. 2000;91:256–60. [PubMed: 10766979]
534.
Sibai BM, Caritis S, Hauth J. Risks of preeclampsia and adverse neonatal outcomes among women with progestational diabetes mellitus. American Journal of Obstetrics and Gynecology. 2000;182:364–9. [PubMed: 10694338]
535.
Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. American Journal of Obstetrics and Gynecology. 1988;158(4):892–898. [PubMed: 3364501]
536.
Murray N, Homer LS, Davis GK, Curtis J, Manzos G, Brown MA. The clinical utility of routine urinalysis in pregnancy: a prospective study. Medical Journal of Australia. 2002;177:477–80. [PubMed: 12405888]
537.
Shennan AH, Waugh JJS. The measurement of blood pressure and proteinuria, Pre-eclampsia. Critchley H, MacLean AB, Poston L, Walker JJ, editors. London: RCOG Press; 2003. pp. 305–24.
538.
Rodriguez-Thompson D, Lieberman ES. Use of a random urinary protein-to-creatinine ratio for the diagnosis of significant proteinuria during pregnancy. American Journal of Obstetrics and Gynecology. 2001;185:808–11. [PubMed: 11641656]
539.
Ferrazzani S, Caruso A, De Carolis S, Martino IV, Mancuso S. Proteinuria and outcome of 444 pregnancies complicated by hypertension. American Journal of Obstetrics and Gynecology. 1990;162:366–71. [PubMed: 2309816]
540.
Waugh JJS, Clark TJ, Divakaran TG, Khan KS, Kilby MD. A systematic review and meta-analysis comparing protein/creatinine ratio measurements and dipstick urinalysis in predicting significant proteinuria in pregnancy. Presented at the British Maternal and Fetal Medicine Society; 20–21 March 2003.University of York;
541.
Chamberlain G, Morgan M. ABC of Antenatal Care; London: BMJ Publishing; 2002.
542.
Buekens P, Alexander S, Boutsen M, Blondel B, Kaminski M, Reid M. Randomised controlled trial of routine cervical examinations in pregnancy. European Community Collaborative Study Group on Prenatal Screening. Lancet. 1994;344:841–4. [PubMed: 7916399]
543.
Iams JD, Goldenberg RL, Meis PJ. The length of the cervix and the risk of spontaneous premature delivery. New England Journal of Medicine. 1996;334:567–72. [PubMed: 8569824]
544.
Goldenberg RL, Klebanoff M, Carey JC. Vaginal fetal fibronectin measurements from 8 to 22 weeks’ gestation and subsequent spontaneous preterm birth. American Journal of Obstetrics and Gynecology. 2000;183:469–75. [PubMed: 10942489]
545.
Goldenberg RL, Mercer BM, Meis PJ, Copper RL, Das A, McNellis D. The preterm prediction study: fetal fibronectin testing predicts early spontaneous birth. Obstetrics and Gynecology. 1996;87:643–8. [PubMed: 8677060]
546.
Mercer BM, Goldenberg RL, Das A. The preterm prediction study: a clinical risk assessment system. American Journal of Obstetrics and Gynecology. 1996;174:1885–95. [PubMed: 8678155]
547.
Newton ER, Barss V, Cetrulo CL. The epidemiology and clinical history of asymptomatic midtrimester placenta previa. American Journal of Obstetrics and Gynecology. 1984;148:743–8. [PubMed: 6702943]
548.
Lauria MR, Smith RS, Treadwell MC, Comstock CH, Kirk JS, Lee W, et al. The use of second-trimester transvaginal sonography to predict placenta previa. Ultrasound in Obstetrics and Gynecology. 1996;8:337–40. [PubMed: 8978009]
549.
Leerentveld RA, Gilberts EC, Arnold MJ, Wladimiroff JW. Accuracy and safety of transvaginal sonographic placental localization. Obstetrics and Gynecology. 1990;76:759–62. [PubMed: 2216220]
550.
Oppenheimer L, Holmes P, Simpson N, Dabrowski A. Diagnosis of low-lying placenta: can migration in the third trimester predict outcome? Ultrasound in Obstetrics and Gynecology. 2001;18:100–2. [PubMed: 11529986]
551.
Sherman SJ, Carlson DE, Platt LD, Medearis AL. Transvaginal ultrasound: does it help in the diagnosis of placenta previa? American Journal of Obstetrics and Gynecology. 1991;164:344. [PubMed: 12796951]
552.
Farine D, Peisner DB, Timor-Tritsch IE. Placenta previa: is the traditional diagnostic approach satisfactory? Journal of Clinical Ultrasound. 1990;18:328–30. [PubMed: 2161001]
553.
Taipale P, Hiilesmaa V, Ylostalo P. Diagnosis of placenta previa by transvaginal sonographic screening at 12–16 weeks in a nonselected population. Obstetrics and Gynecology. 1997;89:364–7. [PubMed: 9052586]
554.
Taipale P, Hiilesmaa V, Ylostalo P. Transvaginal ultrasonography at 18–23 weeks in predicting placenta previa at delivery. Ultrasound in Obstetrics and Gynecology. 1998;12:422–5. [PubMed: 9918091]
555.
Hill LM, DiNofrio DM, Chenevey P. Transvaginal sonographic evaluation of first-trimester placenta previa. Ultrasound in Obstetrics and Gynecology. 1995;5:301–3. [PubMed: 7614132]
556.
Dashe JS, McIntire DD, Ramus RM. Persistence of placenta previa according to gestational age at ultrasound detection. Obstetrics and Gynecology. 2002;99:692–7. [PubMed: 11978274]
557.
Groo KM, Paterson-Brown S. Placenta praevia and placenta praevia accreta: A review of aetiology, diagnosis and management. Fetal and Maternal Medicine Review. 2001;12:41–66.
558.
Ananth CV, Smulian JC, Vintzileos AM. The association of placenta previa with history of cesarean delivery and abortion: a metaanalysis. American Journal of Obstetrics and Gynecology. 1997;177:1071–8. [PubMed: 9396896]
559.
Ananth CV, Demissie K, Smulian JC. Placenta previa in singleton and twin births in the United States, 1989 through 1998: a comparison of risk factor profiles and associated conditions. American Journal of Obstetrics and Gynecology. 2003;188:275–81. [PubMed: 12548229]
560.
Royal College of Obstetricians and Gynaecologists. Placenta praevia: diagnosis and management, Guideline No. 27. London: RCOG; 2001.
561.
Neilson JP. Interventions for suspected placenta praevia. Cochrane Database of Systematic Reviews. 2003;(1):1–19. [PubMed: 12804418]
562.
McFarlin BL, Engstrom JL, Sampson MB, Cattledge F. Concurrent validity of Leopold’s maneuvers in determining fetal presentation and position. Journal of Nurse-Midwifery. 1985;30:280–4. [PubMed: 3854344]
563.
Vause S, Hornbuckle J, Thornton JG. Palpation or ultrasound for detecting breech babies? British Journal of Midwifery. 1997;5:318–9.
564.
Thorp JM Jr, Jenkins T, Watson W. Utility of Leopold maneuvers in screening for malpresentation. Obstetrics and Gynecology. 1991;78:394–6. [PubMed: 1876372]
565.
Olsen K. Midwife to midwife. ‘Now just pop up here, dear...’ revisiting the art of antenatal abdominal palpation. Practising Midwife. 1999;2:13–5. [PubMed: 10723407]
566.
Neilson JP. Symphysis-fundal height measurement in pregnancy. Cochrane Database of Systematic Reviews. 2001;(2) [PubMed: 10796225]
567.
Gardosi J, Francis A. Controlled trial of fundal height measurement plotted on customised antenatal growth charts. British Journal of Obstetrics and Gynaecology. 1999;106:309–317. [PubMed: 10426236]
568.
Macones GA, Depp R. Fetal monitoring, When to screen in obstetrics and gynaecology. Wildschut HIJ, Weiner CP, Peters TJ, editors. London: WB Saunders; 1996. pp. 202–18.
569.
Grant A, Elbourne D, Valentin L, Alexander S. Routine formal fetal movement counting and risk of antepartum late death in normally formed singletons. Lancet. 1989;ii:345–9. [PubMed: 2569550]
570.
Divanovic E, Buchmann EJ. Routine heart and lung auscultation in prenatal care. International Journal of Gynecology and Obstetrics. 1999;64:247–51. [PubMed: 10366046]
571.
Sharif K, Whittle M. Routine antenatal fetal heart rate auscultation: is it necessary? Journal of Obstetrics and Gynaecology. 1993;13:111–3.
572.
Garcia J, Corry M, MacDonald D, Elbourne D, Grant A. Mothers’ views of continuous electronic fetal heart monitoring and intermittent auscultation in a randomized controlled trial. Birth. 1985;12:79–86. [PubMed: 3890874]
573.
Pattison N, McCowan L. Cardiotocography for antepartum fetal assessment. Cochrane Database of Systematic Reviews. 2001;(2) [PubMed: 20091511]
574.
Bricker L, Neilson JP. Routine ultrasound in late pregnancy (> 24 weeks gestation) Cochrane Database of Systematic Reviews. 2001;(2) [PubMed: 10796263]
575.
Bricker L, Neilson JP. Routine Doppler ultrasound in pregnancy. Cochrane Database of Systematic Reviews. 2001;(2) [PubMed: 17636673]
576.
Chien PF, Arnott N, Gordon A, Owen P, Khan KS. How useful is uterine artery Doppler flow velocimetry in the prediction of preeclampsia, intrauterine growth retardation and perinatal death? An overview. BJOG. 2000;107:196–208. [PubMed: 10688503]
577.
Hilder L, Costeloe K, Thilaganathan B. Prolonged pregnancy: evaluating gestation-specific risks of fetal and infant mortality. British Journal of Obstetrics and Gynaecology. 1998;105:169–73. [PubMed: 9501781]
578.
Crowley P. Interventions for preventing or improving the outcome of delivery at or beyond term. Cochrane Database of Systematic Reviews. 2003;(1) [PubMed: 10796167]
579.
Boulvain M, Fraser WD, Marcoux S, Fontaine JY, Bazin S, Pinault JJ, Blouin D. Does sweeping of the membranes reduce the need for formal induction of labour? A randomised controlled trial. British Journal of Obstetrics and Gynaecology. 1998;105:34–40. [PubMed: 9442159]
580.
Melzack R. The short-form McGill pain questionnaire. Pain. 1987;30:191–7. [PubMed: 3670870]
581.
Royal College of Obstetricians and Gynaecologists, Clinical Effectiveness Support Unit. National Sentinel Caesarean Section Audit Report. London: RCOG Press; 2001.
582.
Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. Multivariate analysis of risk. New England Journal of Medicine. 1986;315:81–6. [PubMed: 3724803]
583.
Kitchen WH, Yu VY, Orgill AA, Ford G, Rickards A, Astbury J, et al. Infants born before 29 weeks gestation: survival and morbidity at 2 years of age. British Journal of Obstetrics and Gynaecology. 1982;89:887–91. [PubMed: 6216910]
584.
Lau TK, Lo KW, Rogers M. Pregnancy outcome after successful external cephalic version for breech presentation at term. American Journal of Obstetrics and Gynecology. 1997;176:218–23. [PubMed: 9024118]
585.
Brocks V, Philipsen T, Secher NJ. A randomized trial of external cephalic version with tocolysis in late pregnancy. British Journal of Obstetrics and Gynaecology. 1984;91:653–6. [PubMed: 6743606]
586.
Van Veelan AJ, Van Cappellen AW, Flu PK, Straub MJPF, Wallenburg HC. Effect of external cephalic version in late pregnancy on presentation at delivery: a randomized controlled trial. British Journal of Obstetrics and Gynaecology. 1989;96:916–21. [PubMed: 2673337]
587.
Dugoff L, Stamm CA, Jones OW, Mohling SI, Hawkins JL. The effect of spinal anesthesia on the success rate of external cephalic version: a randomized trial. Obstetrics and Gynecology. 1999;93:345–9. [PubMed: 10074976]
588.
Van Dorsten JP, Schifrin BS, Wallace RL. Randomized control trial of external cephalic version with tocolysis in late pregnancy. American Journal of Obstetrics and Gynecology. 1981;141:417–24. [PubMed: 7282824]
589.
Hofmeyer GJ. External cephalic version for breech presentation before term. Cochrane Database of Systematic Reviews. 2001;(2)
590.
Hofmeyer GJ. External cephalic version facilitation for breech presentation at term. Cochrane Database of Systematic Reviews. 2001;(2) [PubMed: 11687071]
591.
Mahomed K, Seeras R, Coulson R. External cephalic version at term. A randomized controlled trial using tocolysis. British Journal of Obstetrics and Gynaecology. 1991;98:8–13. [PubMed: 1998637]
592.
Hofmeyr GJ. Effect of external cephalic version in late pregnancy on breech presentation and caesarean section rate: a controlled trial. British Journal of Obstetrics and Gynaecology. 1983;90:392–9. [PubMed: 6342657]
593.
Mushambi M. External cephalic version: new interest and old concerns. International Journal of Obstetric Anesthesia. 2001;10:263–6. [PubMed: 15321582]
594.
Hofmeyer GJ. Interventions to help external cephalic version for breech presentation at term. Cochrane Database of Systematic Reviews. 2002;(4) [PubMed: 12076384]
595.
van Loon AJ, Mantingh A, Serlier EK, Kroon G, Mooyaart EL, Huisjes HJ. Randomised controlled trial of magnetic-resonance pelvimetry in breech presentation at term. Lancet. 1997;350:1799–804. [PubMed: 9428250]
596.
Walkinshaw SA. Pelvimetry and breech at term. Lancet. 2002;350:1791–2. [PubMed: 9428246]
597.
Hofmeyr GJ, Kulier R. Cephalic version by postural management for breech presentation. Cochrane Database of Systematic Reviews. 2003;(1) [PubMed: 10796105]
598.
Cardini F, Weixin H. Moxibustion for correction of breech presentation: a randomized controlled trial. JAMA. 1998;280:1580–4. [PubMed: 9820259]
599.
Li Q. Clinical observation on correcting malposition of fetus by electro-acupuncture. Journal of Traditional Chinese Medicine. 1996;16:260–2. [PubMed: 9389098]
600.
Rouse DJ, Andrews WW, Goldenberg RL, Owen J. Screening and treatment of asymptomatic bacteriuria of pregnancy to prevent pyelonephritis: a cost-effectiveness and cost-benefit analysis. Obstetrics and Gynecology. 1995;86:119–23. [PubMed: 7784004]
601.
Petrou S, Sach T, Davidson L. The long-term costs of preterm birth and low birth weight: results of a systematic review Child: Care, Health and Development20012797–115. [PubMed: 11251610]
602.
Connor N, Roberts J, Nicoll A. Strategic options for antenatal screening for syphilis in the United Kingdom: a cost effectiveness analysis. Journal of Medical Screening. 2000;7:7–13. [PubMed: 10807140]
603.
Read JS, Klebanoff MA. Sexual intercourse during pregnancy and preterm delivery: effects of vaginal microorganisms. American Journal of Obstetrics and Gynecology. 1993;168:514–19. [PubMed: 8438920]
604.
Raymond EG, Cnattingius S, Kiely JL. Effects of maternal age, parity, and smoking on the risk of stillbirth. British Journal of Obstetrics and Gynaecology. 1994;101:301–6. [PubMed: 8199075]
605.
Ho KY, Kang JY, Viegas OA. Symptomatic gastro-oesophageal reflux in pregnancy: a prospective study among Singaporean women. Journal of Gastroenterology and Hepatology. 1998;13:1020–6. [PubMed: 9835318]
606.
Kovacs GT, Campbell J, Francis D, Hill D, Adena A. Is Mucaine an appropriate medication for the relief of heartburn during pregnancy? Asia-Oceania Journal of Obstetrics and Gynaecology. 1990;16:357–62. [PubMed: 2099731]
607.
Briggs DW, Hart DM. Heartburn of pregnancy. A continuation study. British Journal of Clinical Practice. 1972;26:167–9. [PubMed: 4556494]
608.
Dick PT.with the Canadian Task Force on the Periodic Health Examination. Prenatal screening and diagnosis of Down Syndrome. 1994. [Accessed 4 September 2003]. pp. 84–98. [ www​.ctfphc.org/Full_Text/Ch08full.htm] [PMC free article: PMC1487598] [PubMed: 8630836]
609.
Bindra R, Heath V, Liao A, Spencer K, Nicolaides KH. One-stop clinic for assessment of risk for trisomy 21 at 11–14 weeks: a prospective study of 15030 pregnancies. Ultrasound in Obstetrics and Gynecology. 2002;20:219–25. [PubMed: 12230441]
610.
Mastrobattista JM, Bishop KD, Newton ER. Wet smear compared with gram stain diagnosis of bacterial vaginosis in asymptomatic pregnant women. Obstetrics and Gynecology. 2000;96:504–6. [PubMed: 11004348]
611.
Krohn MA, Hillier SL, Eschenbach DA. Comparison of methods of diagnosing bacterial vaginosis among pregnant women. Journal of Clinical Microbiology. 1990;27:1266–71. [PMC free article: PMC267539] [PubMed: 2473992]
612.
Royal College of Obstetricians and Gynaecologists. Induction of labour, Evidence-based Clinical Guideline No. 9. London: RCOG Press; 2001.
613.
Department of Health. Unlinked Anonymous Prevalence Monitoring Programme in the United Kingdom. Summary Report from the Unlinked Anonymous Surveys Steering Group, Data to the end of 1998. London: DoH; 1999.
614.
Balano K, Beckerman K, Ng V. Rapid HIV screening during labor. JAMA. 1998;280:1664. [PubMed: 9831996]
615.
Postma MJ, Beck EJ, Mandalia S, Sherr L, Walters MDS, Houweling H, et al. Universal HIV screening of pregnant women in England: cost effectiveness analysis. British Medical Journal. 1999;318:1656–60. [PMC free article: PMC28143] [PubMed: 10373167]
616.
Shey Wiysonge CU, Brocklehurst P, Sterne JAC. Vaginal disinfection during labor for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database of Systematic Reviews. 2002;(3) [PubMed: 12137703]
617.
Kind C, Rudin C, Siegrist C, Wyler C, Biedermann K, Lauper U, et al. Prevention of vertical HIV transmission: additive protective effect of elective cesarean section and zidovudine prophylaxis. AIDS. 1998;12:205–10. [PubMed: 9468370]
618.
Shey Wiysonge CU, Brocklehurst P, Sterne JAC. Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database of Systematic Reviews. 2002;(3) [PubMed: 12137702]
619.
Stray-Pedersen B. Economic evaluation of different vaccination programmes to prevent congenital rubella. NIPH Annals. 1982;5:69–83. [PubMed: 6820478]
620.
Hurtig AK, Nicoll A, Carne C, Lissauer T, Connor N, Webster JP, et al. Syphilis in pregnant women and their children in the United Kingdom: results from national clinician reporting surveys 1994–97. British Medical Journal. 1998;317:1617–19. [PMC free article: PMC28738] [PubMed: 9848899]
621.
Ryan M, Hall SM, Barrett NJ, Balfour AH, Holliman RE, Joynson DH. Toxoplasmosis in England and Wales 1981 to 1992. CDR Review. 1995;5:R13–21. [PubMed: 7532518]
622.
Lappalainen M, Koskiniemi M, Hiilesmaa V, Ammala P, Teramo K, Koskela P, et al. Outcome of children after maternal primary Toxoplasma infection during pregnancy with emphasis on avidity of specific IgG. Pediatric Infectious Disease Journal. 1995;14:354–61. [PubMed: 7638009]
623.
Danielian PJ, Wang J, Hall MH. Long-term outcome by method of delivery of fetuses in breech presentation at term: population based follow up. British Medical Journal. 1996;312:1451–3. [PMC free article: PMC2351189] [PubMed: 8664622]
624.
Krebs L, Topp M, Langhoff-Roos J. The relation of breech presentation at term to cerebral palsy. British Journal of Obstetrics and Gynaecology. 1999;106:943–7. [PubMed: 10492106]
625.
Milsom I, Ladfors L, Thiringer K, Niklasson A, Odeback A, Thornberg E. Influence of maternal, obstetric and fetal risk factors on the prevalence of birth asphyxia at term in a Swedish urban population. Acta Obstetricia et Gynecologica Scandinavica. 2002;81:907–17. [PubMed: 12366480]
626.
van Loon AJ, Mantingh A, Thijn CJP, Mooyaart EL. Pelvimetry by magnetic resonance imaging in breech presentation. American Journal of Obstetrics and Gynecology. 1990;163:1256–60. [PubMed: 2220938]
627.
Hofmeyr GJ, Hannah ME. Planned caesarean section for term breech delivery. Cochrane Database of Systematic Reviews. 2000;(2) [PubMed: 10796165]
628.
Hannah ME, Hannah WJ, Hewson SA, Hodnett ED, Saigal S, Willan AR. Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial. Lancet. 2000;356:1375–83. [PubMed: 11052579]
629.
Gimovsky ML, Wallace RL, Schifrin BS, Paul RH. Randomized management of the nonfrank breech presentation at term: a preliminary report. American Journal of Obstetrics and Gynecology. 1983;146:34–40. [PubMed: 6342396]
630.
Collea JV, Chein C, Quilligan EJ. The randomized management of term frank breech presentation: a study of 208 cases. American Journal of Obstetrics and Gynecology. 1980;137:235–44. [PubMed: 7377243]
631.
Royal College of Obstetricians and Gynaecologists. Guideline No. 20. London: RCOG; Apr, 2001. [Accessed 8 September 2003]. The Management of Breech Presentation. [ www​.rcog.org.uk/guidelines​.asp?PageID=106&GuidelineID=19]
Copyright © 2008, National Collaborating Centre for Women’s and Children’s Health.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

Bookshelf ID: NBK51887
PubReader format: click here to try

Views

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to pubmed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...